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Abstract
Selenium is a nutritional essential trace element. It is required for the activity 
of a number of selenoproteins which contain one or more selenocysteine residues that 
are encoded by in-frame UGA codons. Epidemiological studies also show that there 
is an inverse correlation between the dietary intake of selenium and the incidence of 
cancer. In animals, supra-nutritional but sub-toxic dietary levels of selenium have also 
been shown to have anti-carcinogenic activity in many chemical- and viral-induced 
tumour models and is effective at inhibiting both initiation and post-initiation 
(promotion) stages of tumour progression suggesting that selenium may act by 
inhibiting mutagenic events and also the growth of initiated cells. The 
anti-carcinogenic efficacy of selenium is also highly dependent on chemical form, 
suggesting metabolism is important for its chemoprotective effect.
Selenium at nanomolar concentrations is also essential for the optimum 
growth of cells in culture. However, at higher concentrations, selenium is a potent 
inhibitor of cell growth and it is thought that the growth inhibitory effects of selenium 
in vitro, may be mechanistically relevant to the post-initiation chemopreventive effects 
of selenium.
The mechanism of selenium-induced growth inhibition has been studied in a 
mouse mammary cell line, C57. Of a number of seleno-compounds that have varying 
degrees of chemopreventive activity, only sodium selenite had a significant effect on 
cell growth and caused cell death after a lag period of 48h. This lag period could be 
abolished if glutathione (GSH) was added simultaneously with selenite, suggesting 
that selenite needed to be reduced by GSH to exert its effect. Consistent with this, 
selenodiglutathione (SDG), the primary metabolite from the reaction of selenite and 
GSH, was found to be far more cytotoxic than selenite with micromolar 
concentrations of SDG causing a significant decrease in cloning efficiency within lh.
SDG- and ^C^-induced cytotoxicity were compared since the reaction 
between selenite and GSH has been shown to generate reactive oxygen species. 
H2 O2  also had a rapid effect and reduced the cloning efficiency of C57 cells within lh. 
However, SDG and H2 O2 appeared to be inducing cell death by distinct mechanisms 
as judged by the following observations: (1) SDG was found to reduce the mRNA 
levels of phospholipid hydroperoxide glutathione peroxidase (PHGPX), glutathione 
peroxidase (GPX) and glutathione S-transferase Ya subunit (GST Ya) whereas H2 O2  
had no effect; and (2) SDG induces both 560Kb and 50Kb DNA fragments whereas 
H2 O2  only induces the formation of 560Kb fragments. The cleavage of DNA into 
high molecular weight fragments has been suggested to be indicative of apoptosis. 
However, key morphological markers of apoptosis were not observed with treatment 
of either agent.
To further investigate the mechanism of selenium-induced growth inhibition, a 
genetic approach was adopted. Using a one-step selection strategy, an SDG-resistant 
cell line (B19) was generated from C57 cells. B19 cells were found to be 
cross-resistant to selenite but equally sensitive to H2 O2  as C57 cells which is 
consistent with the conclusions that selenite is acting through the production of SDG 
and that SDG and H2 O2 induce cell death by distinct mechanisms. C57 and B19 cells 
were compared to gain some insight into the possible mechanisms of 
selenium-resistance. Selenium-uptake and GSH concentrations were eliminated as 
possible modes of resistance since these two parameters were unchanged in the B19 
cells. However, the levels of a number of mRNAs were found to be different between
the two cell lines. GST Ya and GST Yc were 2-fold higher in B19 cells whereas 
PHGPX and Bcl-xg were 2-fold lower in B19 cells. Additionally, the 
selenium-labelling protein complement of the two cell lines were compared. Both 
increases and decreases in the labelling or levels of a number of proteins were found 
to be altered in the B19 cells. The most striking differences were the absence in C57 
cells of two 72KDa selenium-labelling proteins.
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1Chapterl 
Selenium: Essential trace element
1.1 Introduction
In the last 40 years it has been recognised that selenium is an essential 
dietary element with syndromes such as Keshan disease, a juvenile 
cardiomyopathy, being attributed to selenium-deficient diets (reviewed in Ge and 
Yang, 1993). Before a biological role had been assigned to selenium it was 
believed that selenium primarily functioned as an antioxidant since it could prevent 
liver necrosis and exudative diathesis, a condition characterised by leakage of 
plasma into sub-cutaneous spaces, induced by a vitamin E-deficient diet (Patterson 
et al., 1957; Schwarz and Foltz, 1957). The first biochemical role for selenium 
was recognised when it was discovered that selenium forms an integral part of the 
antioxidant enzyme, glutathione peroxidase (GPX) (Rotruck et al., 1973). The 
selenium moiety was subsequently found to be in the active site in the form of the 
amino acid residue selenocysteine ([Se]Cys) encoded by an in-frame termination 
UGA codon (Chambers et al., 1986). A number of selenoproteins have since been 
identified that contain one or more UGA-encoded [Se]Cys. These include three 
other glutathione peroxidases, type I tetraiodothyronine deiodinase (ID-I) which is 
primarily expressed in the liver and deiodinates the pro-hormone thyroxine (T4 ) to 
3,5,3'-triodothyronine (T3 ), and a plasma glycoprotein, selenoprotein P, the 
function of which is presently unknown (reviewed in Sunde, 1990).
In addition to being an essential trace element, a number of epidemiological 
studies indicate that dietary selenium can inhibit carcinogenesis (reviewed in Willett 
and Stamper, 1986). This is strongly supported by a wealth of animal studies 
which show that supra-nutritional, but sub-toxic, levels of selenium are protective 
in a number of different tumour model systems (reviewed in Ip, 1986).
In cell culture, selenium is also an essential trace element and is required in 
the nanomolar range for the optimum growth of cells (McKeehan et al., 1976; 
Medina and Obom, 1981). However, in the micromolar range selenium is a potent
2inhibitor of cell growth (Fico et al., 1986). The mechanism by which selenium 
inhibits cell growth is unknown but it has been suggested that the in vivo 
chemopreventive and in vitro anti-proliferative properties of selenium are 
mechanistically related. The purpose of this study has therefore been to investigate 
the growth inhibitory effects of selenium in vitro to identify mechanisms that may 
be potentially important for the chemopreventive properties of selenium.
1.2 Selenium metabolism
Selenium lies in the same group as sulphur in the periodic table and is thus 
chemically similar. In plants and bacteria, inorganic forms of selenium are readily 
metabolised into the seleno-amino acids, selenomethionine ([Se]Met) and [Se]Cys, 
which can substitute for their sulphur analogues in protein synthesis (Burnell and 
Whatley, 1977). However, while selenium may follow pathways of sulphur 
metabolism, the existence of a unique mechanism of [Se]Cys incorporation into 
selenoproteins indicate that selenium-specific pathways exist.
Sulphur is normally metabolised by oxidation whereas selenium generally is 
reduced. The pathways of selenium metabolism are illustrated in figure 1.1. The 
most common form of selenium used in supplementation studies is selenite. 
Selenite is reduced to H2 Se following the reaction pathway characterised by Hsieh 
and Ganther (1977). The intermediate products, selenodiglutathione (SDG) and 
selenopersulphide, have been synthesised and characterised and found to rapidly 
decompose at neutral pH (Ganther, 1968). This suggests that in vivo these 
products are relatively short lived. The reduction of selenite is catalysed by 
glutathione reductase and NADPH but can occur non-enzymatically in the 
presence of excess glutathione (GSH) (Hsieh and Ganther, 1977). H2 Se is highly 
toxic and is either rapidly incorporated into selenoproteins (see section 1.3 and 1.4) 
or detoxified by methylation and excreted as dimethyl selenide in exhaled air or in 
urine as monomethylated seleno-compounds and trimethylselenonium ion (figure 
1.1) (Ganther, 1986; Vadhanavikit et al., 1993). A Se-methyltransferase located in
3N a ^ e Q  Selenium from diet
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Figure 1.1
Intermediary selenium metabolism. Diagram showing essential pathways by which 
inorganic and organic selenium is metabolised into selenoproteins or excreted.
(G represents the thiol-containing tri-peptide, glutathione). See text for details.
4rat liver microsomes which is sensitive to inhibition by arsenite can form 
dimethylselenide from selenite in a cell-free system (Ganther, 1966, Hsieh and 
Ganther, 1977). There also exists a cytosolic methyl-transferase that is less 
sensitive to arsenite inhibition (Hsieh and Ganther, 1977). This arsenite-insensitive 
methyl-transferase may also be responsible for the final methylation step to form 
trimethyl selenonium ion (Mozier et al., 1988). Although methylation is a 
detoxification process, this is to some extent reversible since the selenium atom in 
methylated Se-compounds can be incorporated into GPX indicating that 
demethylation can occur (figure 1.1) (Ip et al., 1991).
[Se]Cys is obtained from the diet or generated either during selenoprotein 
synthesis or from [Se]Met. In mammals, [Se]Met cannot be synthesised from 
inorganic forms of selenium (Cummins and Martin, 1967) but is obtained from 
plants, such as wheat, in the diet (Meltzer et al., 1992). [Se]Met can be converted 
into [Se]Cys by the transulphuration pathway using cystathione p synthase and 
cystathione y  lyase (Esaki et al., 1981) (figure 1.1). [Se]Cys, which is toxic, is 
reduced by selenocysteine p lyase to H2 Se (Esaki et al., 1982), thus allowing Se to 
be recycled into selenoproteins or excreted.
1.3 Selenoprotein synthesis
The mechanism of selenoprotein synthesis has been best characterised in 
bacteria. Eschericia coli have three selenopolypeptides that constitute the 
isozymes of formate dehydrogenase (FDHfj, FDH^ and FDHq) (C ox et al., 1981; 
Sawyers et al., 1991), each containing [Se]Cys encoded by a UGA codon. The 
incorporation of [Se]Cys is co-translational (Zinoni et al., 1987) and four genes 
have been identified (sel AJ$,C and D) that are required for the correct translation 
of UGA into [Se]Cys (Leinfelder et al., 1988a, 1988b) (Figure 1.2). The sel C 
gene product encodes a tRNA molecule, tRNAsec, that is charged with L-serine by 
seryl-tRNA synthetase to form seryl-tRNAsec (Leinfelder et al., 1988b). 
However, the amino-acylation of tRNAsec exhibits and Kj^ values that are
5SEL C Ser
c
SEL A
SELD + HjSc + ATP
5 ’
Met
[Se]Cys
AUG UGA 3’
Figure 1.2
Co-translational insertion of selenocysteine during selenoprotein synthesis in 
prokaryotes. Schematic representation of the gene products and other factors 
required for selenoprotein synthesis. See text for details.
610-fold lower than those of tRNAser (Baron and Bock, 1991). A major structural 
determinant distinguishing tRNAsec from tRNAser is the amino acid acceptor stem 
which consists of 8  bp in tRNAsec and 7 bp in tRNAser and all other tRNAs of 
E.coli (Leinfelder et al., 1988b).
Seryl-tRNAsec is converted to selenocysteyl-tRNAsec by a two-step 
process catalysed by the sel A and sel D gene products, sel A encodes [SejCys 
synthase which is a 600kDa homo-oligomer composed of 50kDa subunits 
(Forchhammer et al., 1991). [Se]Cys synthase is responsible for the 2,3- 
elimination of water from the seryl residue giving rise to an aminoacrylyl-tRNAsec 
intermediate. The addition of H2 Se with the concomitant hydrolysis of one 
molecule of ATP is catalysed by the sel D gene product (figure 1.2) (Forchhammer 
and Bock, 1991). The sel B gene encodes a protein that functions in the 
translation step and has considerable homology with the elongation factor EF-Tu 
(Forchhammer et al., 1989, 1990). Both proteins bind GTP and probably serve 
analogous functions. However, while SEL B binds tRNAsec stoichiometrically, 
EF-Tu binds with low affinity (Forster et al., 1990). It is therefore thought that 
SEL B is an elongation factor specific for [SeJCys incorporation (figure 1.2).
Readthrough of the normally terminating UGA codon also requires 
structural features of the selenoprotein mRNA (figure 1.2). Deletion experiments 
with the fdhF  gene from E.coli demonstrated that a sequence of about 40 bases 
directly downstream of the UGA codon, which could fold into a putative stem- 
loop structure, was required for efficient [Se]Cys incorporation (Zinoni et al.,
1990). Searches of different prokaryotic selenoprotein mRNAs also revealed 
similar structures in the vicinity of the UGA codon (Zinoni et al., 1990). Point 
mutational experiments are consistent with the idea that the correct folding of this 
structure and sequence elements within the loop region are absolutely required and 
it has been hypothesised that SEL B interacts with this structure to form a 
quaternary complex at the mRNA together with GTP and selenocysteyl-tRNAsec 
(figure 1.2) (Heider et al., 1992).
7The process of selenoprotein synthesis in eukaryotes is less well 
understood. However, evidence suggests that the mechanism may be similar to the 
prokaryotic situation. Eukaryotes contain a seryl-tRNA that recognises the UGA 
codon and is converted to selenocysteyl-tRNA in vivo (Hatfield, 1985; Lee et al., 
1989). Additionally, the selenocysteyl tRNAsec is ubiquitous in the animal 
kingdom (Lee et al., 1990) and the human homologue can complement a lesion in 
the tRNAsec gene in E.coli, despite there being little sequence homology between 
the two tRNAs, suggesting functional conservation (Baron et al., 1994). Putative 
stem-loop structures identified in selenoprotein mRNAs are also thought to be 
required for eukaryotic selenoprotein synthesis (Berry et al., 1991a). Deletion 
experiments have shown that a 200 nucleotide stretch in the 3' untranslated region 
of type I tetraiodothyronine deiodinase is essential for [Se]Cys incorporation and 
that it can be functionally substituted for by the 3' untranslated region of rat GPX 
mRNA. The ID-I and GPX 3' untranslated regions share little sequence homology 
suggesting that it is a structural, rather than a sequence determinant of the 3' 
untranslated region required for [Se]Cys incorporation (Berry et al., 1991a). The 
fact that these are located in the 3' untranslated region of the mRNA rather than 
immediately downstream of the UGA codon, as is the case in prokaryotes, could 
suggest there are fundamental mechanistic differences between pro- and eukaryotic 
selenoprotein synthesis. However, in both cases it is believed that the stem-loop 
structure must fold back and interact with the translational machinery to facilitate 
[Se]Cys incorporation. The different spatial positioning of the stem-loop 
structures in relation to the UGA codon may therefore be incidental since the size 
of the stretch of the mRNA looped out is unlikely to be functionally significant.
1.4 Mammalian selenoproteins
In rats, 80% of the body's selenium is in the form of [Se]Cys (Hawkes et 
al., 1985). Probably therefore, selenium primarily functions through
selenoproteins. A number of mammalian selenoproteins have been identified. ID-I
8is a selenium-dependent enzyme identified as the enzyme being responsible for the 
decreased production of T3  in selenium-deficient animals (Arthur and Beckett, 
1989; Arthur et al., 1991). Classification of ID-I as a selenoprotein was confirmed 
by cloning and sequencing of the ID-I cDNA which was found to contain an 
in-frame UGA codon (Berry et al., 1991b). Selenoprotein P is located in the 
plasma and contains a putative 10 [Se]Cys residues as judged by sequencing (Hill 
et al., 1991). However, amino acid analysis and measurement of selenium content 
show an average of 7.5 [SejCys residues/polypeptide suggesting that some of the 
in-frame UGA codons may act as termination codons (Read et al., 1990). The 
function of selenoprotein P is unknown. However, it contains 60% of plasma 
selenium (Read et al., 1990) and it has been postulated that it may be involved in 
selenium transport since in selenium-deficient rats, selenoprotein P is rapidly 
synthesised in preference to other selenoproteins, such as GPX, has a rapid 
turnover and its synthesis precedes the appearance of selenium in tissues 
(Motsenbocker and Tappel, 1982; Burk and Gregory, 1982). However, the fact 
that selenium is covalently incorporated into selenoprotein P and that dietary 
selenium status does not affect its turnover argues against selenoprotein P being 
specifically involved in selenium transport (Burk et al., 1991; Read et al., 1990). 
Alternatively, it has been suggested that selenoprotein P may have an antioxidant 
function since the appearance of selenoprotein P, but not GPX, correlates with the 
protective action of selenite against diquat-induced liver necrosis and lipid 
peroxidation, when injected into selenium-deficient animals (Burk et al., 1980; 
Burk etal., 1991).
The most extensively characterised selenoproteins are the 
[Se] Cys-containing glutathione peroxidases. These function to protect against the 
generation and effects of reactive oxygen species and are related by the fact that 
they all utilise GSH to reduce hydroperoxides (Combs and Combs, 1986). The 
family consists of four members, each with subunits ~20KDa in size, that differ in 
their expression patterns, subcellular localisation and substrate specificity. Three
9members, namely GPX, PGPX and GPX-GI, act as homo-tetramers (Epp et al.,
1983; Takahashi et al., 1987; Chu et al., 1993) whereas a fourth member,
PHGPX, acts as a monomer) (Ursini et a l , 1985).
GPX, which is cytosolic and ubiquitously expressed, is active against 
hydrogen peroxide and organic peroxides, such as fatty acid hydrperoxides. It is 
not, however, active against phospholipid hydroperoxides (Sevanian et al., 1983; van Kuijk 
etaU  1986).
GPX-GI has similar a substrate specificity to GPX. However, GPX-GI is 
only 61% homologous to GPX at the nucleotide level and is antigenically distinct 
from GPX. GPX-GI also has a more restricted tissue distribution than GPX, with 
levels highest in liver and colon in humans and the gastro-intestinal tract in rodents 
(Chu etaU  1993).
PGPX is a plasma glycoprotein primarily synthesised in kidney in rodents 
and kidney, liver, heart lung and breast in humans (Chu et al., 1992; Yoshimura et 
al., 1991). It is immunologically distinct from GPX (Takahashi et al., 1987) and 
can reduce hydrogen peroxide and both fatty acid and lipid hydroperoxides 
(Yamamoto and Takahashi, 1993).
PHGPX is mostly cytosolic but is also bound to some extent to cell 
membranes. It is ubiquitously expressed and can reduce a wide range of 
hydroperoxides and is active on cholesterol hydroperoxides as well as many 
phospholipid hydroperoxides (Maiorino et al., 1990).
1.5 Selenium-binding proteins
SDS/PAGE and 2D gel analysis of proteins from cells labelled in vivo and 
in vitro with [75Se]selenium reveal a number of selenium labelled proteins 
(Danielson and Medina, 1986; Behne et al., 1988). While many of these are 
probably, as yet, unidentified selenoproteins, some have been molecularly cloned 
and shown to bind selenium in an as yet unidentified form and not as 
UGA-encoded [Se]Cys.
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A 14KDa liver selenium-associated protein was purified and identified as 
liver fatty acid binding protein (L-FABP) (Bansal et al., 1989). L-FABP is a 
member of a family of fatty acid-binding proteins that interact with long chain fatty 
acids. Their exact function in vivo is unknown. However, L-FABP has been 
associated with hepatocyte growth since the level of immunostained L-FABP is 
markedly increased during mitosis of all dividing hepatocytes of rat newborn, 
immature, adult and regenerating livers (Custer and Sorof, 1984, 1985; Bassuk et 
al., 1987). Additionally, linoleic acid, which is a ligand for L-FABP, requires the 
overexpression of L-FABP to stimulate the growth of hepatocytes (Keller et al.,
1992). The functional significance of selenium-binding is unknown.
Another group of selenium-binding proteins are of molecular weight 
56-58kDa. One has been shown to be protein disulphide isomerase (PDI) which 
has dithiol-disulphide oxidoreductase activity and is involved in assisting protein 
folding. Interestingly, the increased levels or labelling of PDI correlated with 
selenite-induced inhibition of DNA synthesis (Morrison et al., 1988; Sinha et al.,
1993). However, it is unclear how functionally significant this association is since 
liver PDI activity is unaffected by selenium-deficiency (Arthur et al., 1991) and in 
cultured mammary cells PDI activity is independent of selenium concentration in 
the medium (Sinha et al., 1993). However, under conditions of iodine deficiency 
liver PDI activity can be increased by selenium supplementation (Arthur et al.,
1991).
Another liver selenium-associated protein of molecular weight 56kDa 
(SP56) has been molecularly cloned by Medina's group (Bansal et al., 1990). The 
function of SP56 is unknown but it does share a high degree of homology (97%) 
with an acetominophen-binding protein (AP56) (Lanfear et al., 1993). AP56 was 
previously identified as a protein that binds acetominphen metabolites during 
acetominophen-induced hepatoxicity (Pumford et al., 1992; Bartolone et al.,
1992). However, it is not known if AP56 binds selenium and what role selenium 
has for either of these proteins. AP56 has been postulated to be involved in
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acetominophen toxicity. However, it is unknown if AP56 is involved in 
acetominophen detoxification per se, or whether it provides some vital function 
that is targeted by acetominophen, resulting in its inactivation and toxicity. The 
high degree of homology between SP56 and AP56 suggests that SP56 probably 
serves a similar function. However, both proteins are differentially regulated with 
SP56 primarily expressed in liver, kidney and lung and AP56 expressed mainly in 
liver (Lanfear et al., 1993).
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Chapter 2 
Selenium: Anti-carcinogenic agent
2.1 Anti-carcinogenic effects of selenium in humans
A number of studies have shown selenium to have anti-carcinogenic 
properties in humans. Ecological studies indicate an inverse correlation between 
geographical areas of low selenium intake with the incidence of certain cancers 
such as oesophageal and primary liver cancer (Jaskiewicz et al., 1988; Yu et al., 
1988). In a more comprehensive study, Schrauzer et al. (1977) showed that the 
dietary selenium intakes in 27 countries inversely correlates with cancer mortalities 
from tumours of colon, rectum, prostate, breast, ovary, lung and leukaemia. 
Weaker correlations were also noted for pancreas, bladder and skin. One possible 
limitation of this study is that dietary intakes were calculated from average 
selenium concentrations of food sources. Since selenium content of food can vary 
widely depending on the soil levels in which they are grown, putative selenium 
intake, calculated from average selenium concentrations of food sources, may not 
necessarily be a reliable reflection of actual selenium intake. However, when blood 
selenium levels, which are a more accurate indicator of selenium intake, from 
normal donors from 22 different countries and 19 states were measured and 
compared, similar conclusions were obtained (Schrauzer et al., 1977). Blood 
levels are therefore often used to assess selenium intake, although the exact 
dose-effect relationship is not determined. An alternative measurement of selenium 
intake is levels of selenium in toenail tissue. This may have several advantages 
over serum selenium measurements. Serum selenium levels are a short term 
measure of selenium-intake and may fluctuate over periods of days to weeks 
(Thompson and Robinson, 1989). In contrast, toenail selenium levels represent the 
selenium status over several months and so the intra-individual variation in toenail 
levels for individuals having the same intake may be less than those for serum 
(Morris et al., 1983).
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From the ecological studies it might be expected that selenium levels of 
cancer patients would be lower than those of healthy individuals. Indeed, in such 
case-control studies, using both serum and toenail levels as indicators of intake, 
inverse relationships between selenium levels and cancer has been observed 
(Broghamer et al.,1976; Rogers et al., 1991). However, since serum selenium 
levels are measured post-diagnosis, the possibility exists that lower selenium levels 
are due to the disease rather than a cause. Cancer often leads to decreased intake 
of nutrients and dietary intake levels of certain nutrients may thus be lowered due 
to a consequence of the disease, Additionally, selenium has been shown to localise 
and become concentrated in tumours (Cavalieri et al., 1966). A large tumour 
could therefore have a marked effect on measured selenium intake levels.
The use of prospective studies overcomes any confounding effects cancer 
may have on blood selenium levels. Such studies measure selenium levels before 
the diagnosis of cancer and then in follow-up studies during which cancer is 
diagnosed, any association between selenium levels and the risk of developing 
cancer can be assessed. Many studies have shown that individuals having low 
selenium levels have an increased risk of developing cancer. Where specific sites 
have been analysed, selenium has been shown to be protective against 
gastro-intestinal, prostate, lung and haematological tumours (Willett et al., 1983; 
Ringstad et al., 1988; van den Brandt et al., 1993). However, this is not a 
completely consistent finding and some studies have found selenium levels to have 
no effect on cancer risk (Nomura et al., 1987). One explanation for these 
conflicting studies is confounding factors that are difficult to control for, such as 
interaction of selenium with other nutrients. For example, the anti-carcinogenic 
effect of selenium is most significant in diets low in vitamin E, C or (3 carotene 
(Rogers et al., 1991; van den Brandt et al., 1993; Willett et al., 1983). Therefore 
in populations consuming high doses of vitamins, the protective effect of selenium 
may be diminished. The influence of dietary factors may also explain why there 
does not appear to be an absolute intake of selenium required for a
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chemopreventive effect. For example, using serum selenium levels as an indicator 
of selenium intake, both 5 and 6 year follow-up prospective studies in the U.S.A. 
and Finland, respectively, found low selenium intakes to be associated with an 
increased risk of developing gastro-intestinal cancers (Willett et al., 1983; Salonen 
et al., 1984). However, in the U.S.A. study, the lowest quintile selenium level, 
which had the highest risk of developing cancer, was actually 2-fold higher than the 
healthy control levels in the Finland study (Willett et al., 1983; Salonen et al.,
1984). Therefore, while the protective effect of selenium may be qualitatively 
similar between populations, the absolute levels required to give an effect will be 
dependent on other factors such as diet which will vary between populations. 
Another confounding factor may be gender since some studies have found the 
chemopreventive effect of selenium to be greatest in males (Kok et al., 1987). 
Different cancers may also have different confounding effects. Therefore, in 
studies where total cancer incidence has been analysed, protective effects against 
individual cancers may be masked by the occurrence of other cancers which are 
less sensitive to selenium inhibition. The form of selenium ingested is also likely to 
be an important confounding factor for the chemopreventive effect and it is 
unknown what different forms exist in different food sources. It might be argued 
that toenail or serum selenium levels is a measure of bioavailability. However, it 
does not necessarily follow that bioavailability correlates with chemopreventive 
activity.
Taking into consideration the limitations of epidemiological studies, the 
evidence for a chemopreventive function for selenium is suggestive but is by no 
means conclusive. A more direct approach to address this question is the use of 
intervention trials. Linxian County, China, has the world's highest rate of 
oesophageal/stomach cancer. In a randomised trial involving 29,584 adults, 
supplements of 1-2 times the U.S. recommended daily amount of vitamin E, [3 
carotene and selenium for a period of 5.25 years were found to significantly 
decrease mortality rates and that this was mainly due to a lower incidence of
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stomach cancer (Blot et al., 1993; Taylor et al., 1994). However, selenium alone 
was not used and so it is difficult to attribute any significant function to selenium. 
Another study conducted in Qidong County, which has the second highest rate of 
primary liver cancer (PLC) in China, used selenium alone in intervention trials. 
Either inorganic selenium in the form of anhydrous sodium selenite or selenium in 
the form of selenized yeast was used to supplement either (1) the general 
population of Qidong County, (2) individuals who were positive for the Hepatitis 
B virus surface antigen or (3) members of families with a history of high rates of 
PLC (Yu et al., 1991). Supplementation periods lasted for 5,4 and 2 years 
respectively. The results showed that both forms of selenium had a significant 
inhibitory effect on PLC incidence (Yu et al., 1991).
2.2 Anti-carcinogenic effects of selenium in animals
Much evidence for the chemopreventive effects of selenium has come from 
animal studies which show that dietary selenium at levels 10-20 fold higher than 
the dietary minimum can inhibit a variety of chemical- and virus-induced cancers 
without any adverse toxic effects (reviewed in Ip, 1986; Medina, 1986; Vemie,
1984). The carcinogens against which selenium is active include both direct-acting 
chemicals, such as methylnitrosourea (MNU), and those requiring metabolic 
activation, such as 7,12-dimethylbenz[a]anthracene (DMBA). Generally, selenium 
is found to reduce tumour incidence, latency and yield, and target organs include 
skin (Shamberger, 1970), colon (Birt et al., 1982), liver (Griffin and Jacobs, 1977) 
mammary gland (Welsch et al., 1981), pancreas (Kise et al., 1990) and lung 
(El-Bayoumy etal., 1993) (table 1.1).
2.3 Mammary tumorigenesis as a model for studying the anti-carcinogenic 
effects of selenium
Most studies measuring the chemopreventive effects of selenium have 
administered selenium during the whole experiment and therefore not examined the
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Species Organ Carcinogen
Rat Liver DAB, AAF
Rat Colon DMH, MAM, BOP
Rat Mammary gland AAF,MNU, DMBA
Mouse Mammary gland MMTV, DMBA
Mouse Skin DMBA
Hamster Pancreas BOP
Mouse Lung NNK
Table 1.1
Models of chemical-induced carcinogenesis in which selenium supplementation has 
been shown to have an inhibitory effect (adapted from Medina,!(1986) and 
El-Bayoumy et al. (1993)).
Abbreviations:
DAB, 3-methylaminoazobenzene; AAF, 2-acetylaminofluorine; DMH, 
dimethylhydrazine; MAM, methylazoxymethanol acetate; AOM, azoxymethane; 
BOP, bis(2-oxopropyl)-nitrosamine; MNU, methylnitrosourea; DMBA, 7,12- 
dimethylbenz[a]anthracene; NNK, 4-(methylnitrosamino)-l-(3-pyridyl)-l- 
butanone.
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stages of neoplastic progression at which selenium is most active. In theory, 
because of the multistage nature of carcinogenesis, selenium could act at a number 
of stages by a variety of mechanisms. Initiation may be inhibited by selenium 
preventing mutations induced by carcinogens. Alternatively, selenium could 
prevent the outgrowth of initiated cells or may directly inhibit tumour cell growth. 
Due to its multi-step nature, mouse mammary tumorigenesis has been a useful 
system in studying the stage(s) of carcinogenesis at which selenium is most 
effective.
2.3.1 The biology of mouse mammary tumorigenesis
Mouse mammary tumours develop through a number of characteristic 
preneoplastic states (DeOme et al., 1959, 1978). Preneoplastic lesions arise 
spontaneously at a low frequency (Medina and Kittrell, 1987) but this can be 
increased by chemical carcinogens (Medina and Warner, 1976; Medina, 1976), 
hormone treatment (Medina, 1973; Lanari et al., 1986) and mouse mammary 
tumour virus (MMTV) (DeOme et al., 1959). The study of these preneoplastic 
lesions has been greatly facilitated by the ability of mammary tissue to be 
transplanted into syngeneic mice. This involves "clearing” the mammary fat pad by 
surgically removing the host mammary epithelium. The cleared mammary fat pad 
then acts as an in vivo culture system for the transplantation of foreign isogenic 
mammary epithelial tissue. The two most commonly found preneoplastic lesions 
are hyperplastic alveolar nodules (HAN) and ductal hyperplasias (DH). HAN and 
DH are believed to be precursors to a neoplastic state since they both develop into 
adenocarcinomas when transplanted into the cleared mammary fat pad of syngeneic 
mice at a higher frequency than normal mammary tissue (DeOme et al., 1959; 
Medina, 1973). The frequency of HAN and DH development is highly dependent 
on the strain of mouse and inducing agent. Of the two preneoplastic lesions, most 
studies have been conducted with HAN. In addition to the increased tumorigenic 
potential of HAN, there are a number of other features that distinguish the HAN
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preneoplastic state from normal mammary tissue. HAN are immortal and can be 
serially transplanted indefinitely into cleared mammary fat pads of syngeneic mice. 
Some of these transplants, termed hyperplastic outgrowth (HOG) lines, have been 
serially transplanted for over 20 years (Medina, 1988). In contrast, normal 
mammary cells can only be transplanted for 5-7 generations after which they lose 
their growth potential (Daniel et al., 1975). Morphologically, HOG lines derived 
from primary HAN resemble differentiated alveolar cells of the pregnant mammary 
gland. However, this differentiated state is not ovarian hormone-dependent since 
HOG lines retain their alveolar morphology when transplanted into virgin mice 
(Medina, 1988). HAN-derived HOG lines are therefore generally characterised as 
a population of immortal cells with a differentiated alveolar morphology with a 
higher than normal potential to form tumours.
HOG lines differ from neoplastic cells in that they are still responsive to 
growth controls that regulate normal mammary cells. For example, HOG lines are 
dependent on fat pad stroma and do not overgrow uncleared normal mammary 
pads (DeOme et al., 1959). Furthermore, normal mammary cells when 
transplanted with preneoplastic alveolar nodule cells significantly inhibit the 
tumorigenic potential of the alveolar cells (Medina et al., 1978). HOG lines 
therefore require additional alterations in order to escape this growth regulation 
and become neoplastic. This transition occurs spontaneously to varying degrees 
for different HOG lines but can be induced by treatment with various carcinogens 
orMMTV (Medina, 1973; Medina etal., 1978).
The development of HAN and DH from normal mammary cells is unlikely 
to involve a single genetic event. Indeed, a number of studies have demonstrated 
that the development of preneoplastic lesions involves at least four dissociable 
events. A series of cell lines derived from normal mammary epithelial tissue gave 
rise to both ductal and alveolar outgrowth lines (figure 1.3A) (Kittrell et al., 1992). 
Transplantation assays revealed that the ductal outgrowth lines and one alveolar 
outgrowth line (TM3) were immortal but did not go on to develop tumours
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(A) Summary of chare ten sties of mammary epithelial cell lines and outgrowth lines as 
derived by Medina and Kittrell (1993) and Medina et al. (1993a,b).
(B) Biological states of mouse mammary tumour progression. Based on data from 
Medina (1988), Medina and Kittrell (1993) and Medina et al. (1993a,b).
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(Medina and Kittrell, 1993; Medina et al., 1993a). This indicates that immortality 
and tumorigenicity arise from at least two separate genetic alterations. The 
converse situation has also been demonstrated, whereby tumorigenic alveolar 
hyperplasias have been generated that have finite life-spans (Miyamoto et al., 
1990). This suggests that the phenotypic features of preneoplasia may arise 
independently and do not need to occur in any particular chronological order 
during mammary tumour progression. The outgrowth line, TM3, also differed in 
other respects from the other alveolar outgrowth lines, which were typically 
preneoplastic (Medina et al., 1993a). Although TM3 outgrowth was 
morphologically alveolar in non-pregnant female mice, this phenotype was 
hormone-dependent to a certain degree since when TM3 cells were transplanted 
into ovarectomized mice, both growth and alveolar differentiation were markedly 
diminished (Medina et al., 1993a). In contrast, growth and differentiation of the 
other alveolar outgrowth lines was unaffected by ovarectomy (figure 1.3A) 
(Medina et al., 1993a). Epidermal growth factor (EGF) independence also 
appeared to be a characteristic associated with preneoplastic development 
EGF-dependence for growth was displayed by the progenitor cell lines that gave 
rise to the outgrowth lines (figure 1.3A) (Kittrell et al., 1992). However, cell lines 
established from the outgrowth lines, displayed a diminished dependence for EGF 
in comparison to their respective progenitor cell lines (figure 1.3A) (Medina et al., 
1993b). In contrast, the TM3 progenitor cell line and TM3 cell line established 
from the TM3 outgrowth line displayed an equal dependence for EGF (figure 
1.3A) (Medina et al., 1993b). The characterisation of preneoplasic lines has 
enabled mammary tumorigenesis to be divided into discrete identifiable stages 
(figure 1.3B)
2.3.2 Stage-specific effects of selenium
Mouse mammary tumours that develop through characteristic preneoplastic 
states can be induced by the carcinogen 7,12-dimethylbenz[a]anthracene (DMBA)
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(Medina, 1978). The reproducibility of this model has been used to assess the 
efficacy of selenium to inhibit the three definable stages of mammary tumour 
development: preneoplasia development, progression of preneoplasia to a 
neoplasic state and growth of the neoplastic state. A number of studies indicate 
that selenium is most effective during the early stages of mammary tumorigenesis, 
that is initiation and preneoplasia development. Medina and Shepherd (1981) 
demonstrated that the formation of DMBA-induced preneplastic lesions is 
significantly inhibited by selenium supplementation. Additionally, selenium had an 
inhibitory effect on tumour yield if given either only during DMBA administration 
or after DMBA treatment. This indicates that selenium is effective at both 
initiation and promotion stages. Later stages of tumour progression appear less 
sensitve to the inhibitory effects of selenium since mammary tumour development 
from only 5 of 14 preneoplastic outgrowth lines was inhibited (Medina and Lane, 
1983). In contrast, the growth of mammary tumour cells appears relatively 
refractory to growth inhibition by selenium since only 3 of 36 mammary tumours 
transplanted into syngeneic mice were found to be inhibited by selenium (Medina 
and Lane, 1983). The ability of selenium to inhibit the early stages of 
tumorigenesis has also been demonstrated in organ culture. Treatment with 
DMBA of whole mammary gland, cultured in vitro, results in the appearance of 
nodule-like alveolar lesions (NLAL) which can be identified microscopically 
(Kundu et al., 1978). These lesions are believed to be analogous to the in vivo 
ocurring HAN since NLAL retain their alveolar morphology when serially 
transplanted into virgin mice and have an increased tumour-producing capability 
(Telang et al., 1979). Selenium in the culture medium during or after DMBA 
administration was found to inhibit both the yield and incidence of NLAL 
formation suggesting that both initiation and promotional stages of mammary 
tumorigenesis are sensitive to selenium inhibition (Chatteijee and Banerjee, 1982).
Similar stage-specific effects of selenium have also been demonstrated in 
DMBA-induced mammary tumours in the rat. Rat mammary tumours are thought
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to develop in a similar manner to mouse mammary tumours. Ductal and alveolar 
lesions that resemble those of the mouse can be induced by DMBA (Beuving et al., 
1967a). Additionally, both types of lesions retain their respective morphological 
structure when transplanted into cleared mammary fat pads and develop into 
tumours (Beuving et al., 1967b; Beuving, 1968). Ip (1981) showed by giving rats 
restricted periods of selenium supplementation, that selenium was effective when 
administered during the 2 weeks before and after DMBA treatment, or when given 
continuously for 2-24 weeks after DMBA treatment. The inhibitory effect of 
selenium when given during tumour promotion, that is after DMBA treatment, was 
reversible since selenium given for a shorter period of 2-12 weeks after DMBA 
treatment resulted in a similar tumour yield as unsupplemented control groups. In 
contrast to the effect on tumour yield of selenium given during or early after 
DMBA treatment, selenium given late (12-24 weeks) after carcinogen treatment 
had little effect. The maximum protective effect of selenium was observed when 
selenium was given continuously for the duration of the experiment starting 2 
weeks prior to the administration of DMBA (Ip, 1981). The efficacy of selenium 
to inhibit various stages of DMBA-induced mammary tumorigenesis can thus be 
summarised (figure 1.4).
While it is apparent that selenium can act in a stage-specific manner it is not 
clear if this applies to all tumour models. In different tumour models tumour 
progression occurs by a number of different pathways involving the activation and 
inactivation of different oncogenes and tumour suppressor genes, respectively. 
One of the genetic events associated with DMBA-induced mammary tumours is an 
A-T transversion at codon 61 of the H-ras gene (Mangues and Pellicer, 1992). 
However, if DMBA-induced HAN are serially transplanted as outgrowth lines, the 
resulting tumours contain the wild-type codon 61 of H-ras (Kumar et al., 1990). 
This implies that DMBA-induced mammary tumours can arise from at least two 
different mechanisms, with only one pathway requiring activation of H-ras. 
Therefore, while selenium is most effective at inhibiting early events of
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Figure 1.4
Schematic representation showing the relative chemopreventive activity of 
selenium when administered during different stages of DMBA-induced 
mammary tumour development. Adapted from Medina (1986).
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DMBA-induced mammary tumours, this may not apply to all tumours that have 
arisen through different pathways. For example, triphenylselenonium chloride is 
effective at inhibiting both initiation and post-initiation events of DMBA-induced 
mammary tumorigenesis but is only effective during the post-initiation phase of 
methylnitrosourea-induced mammary tumours (Ip et al., 1994a). Additionally, 
later stages of tumorigenesis may be sensitive to selenium in other tumour models 
since selenium has been shown to inhibit the in vivo growth of a number of fully 
malignant tumour cells including human mammary MCF-7 tumour cells (Watrach 
et al., 1984), transplantable rat mammary tumour MT-W9B (Ip et al., 1981), 
canine mammary carcinoma cells (Watrach et al., 1982), Ehrlich ascites cells 
(Greeder and Milner, 1980) and L1210 leukaemia cells (Milner and Hsu, 1981).
2.3.3 The anti-carcinogenic effects of selenium is dependent on chemical form
The biological activity of selenium is highly dependent on chemical form. 
For example, while levels of four or more parts per million (ppm) of selenium in 
the diet in the form of selenite causes a depression in growth rate of rats, 
suggestive of a toxic effect, triphenylselenonium may be tolerated up to levels of 
200ppm without any adverse effects (Ip et al., 1994a, 1994b).
Regarding the chemopreventive effects of selenium, a number of chemical 
forms, such as 6-phenyl (6H)-isoselenazolo [4,3-d] pyrimidone, 
p-methoxybenzeneselenol and l,4-Phenylenebis(methylene)selenocyanate (p-XSC) 
have been shown to be effective at inhibiting the growth of leukaemia cells and 
reducing the yield of chemical-induced stomach and colon tumours, respectively 
(Ito et al., 1990; El-Bayoumy, 1985; Reddy et al., 1992). p-XSC  has also been 
shown to inhibit chemically-induced mouse lung tumours (El-Bayoumy et al.,
1993). The relative chemopreventive activities of different selenium compounds 
has been most extensively studied using the DMBA-induced mammary tumour 
model. Selenite is one of the most commonly tested forms and is generally one of 
the more active compounds, being more effective than [Se]Met (Thompson et al.,
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1984; Ip and Hayes, 1989). This is probably, in part, due to the non-specific 
substitution of seleno-amino acids for their sulphur analogues in sulphur 
metabolism since under conditions of limiting dietary methionine, the 
chemopreventive effect of [Se]Met was diminished whereas selenite was not (Ip, 
1988). This suggests that [Se]Met can be diverted into methionine metabolism and 
therefore reduce the quantity of selenium available for anti-carcinogenic purposes. 
Consistent with this, tissue selenium levels increased under methionine limiting 
conditions in [Se]Met-supplemented rats (Ip, 1988). The absolute tissue selenium 
levels are higher in [Se]Met-supplemented rats than selenite-supplemented rats at 
equal dietary leves of selenium (Ip and Hayes, 1989). This indicates that while 
there is a general dose-dependent effect between dietary and tissue selenium levels, 
absolute tissue selenium levels may be a poor indicator of chemopreventive 
efficacy. Indeed, triphenylselenonium chloride administered in the diet at 30 ppm 
reduced the yield of DMBA-induced mammary tumours by 69% but did not 
significantly affect tissue selenium levels (Ip et al., 1994a). A poor correlation 
between tissue selenium levels and chemopreventive efficacy was also observed for 
selenium-enriched garlic and onion and brazil nut which is a naturally selenium-rich 
food (Ip and Lisk, 1994a, 1994b). It is therefore clear that the chemopreventive 
action of selenium is not due to the element per se but rather is highly dependent 
on its chemical form implying that selenium metabolism is important. However, it 
is unclear what these critical metabolic pathways and chemical forms are.
Using the DMBA-induced mammary tumour model, a series of 
experiments, set out to identify metabolites of selenium important for its 
chemopreventive effect, compared the anti-carcinogenic effects of inorganic 
selenite with a number of synthetic compounds that enter the organic selenium 
pool after selenite reduction to H2 Se. These included Se-methylselenocysteine 
(SMSC), selenobetaine (SB), selenobetaine methyl ester (SBME), dimethyl 
selenoxide (DMS) and trimethyl selenonium ion (TMS+) which is the product from 
the final methylation step in selenium detoxification. Based on metabolic studies
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using double-labelled 14C and 75Se seleno-compounds and analysis of excretory 
products, SMSC and SB form monomethyl selenol and S>BME and DMS feed into 
dimethyl selenide (Foster et al., 1986a, 1986b; Vadhanavikit et al., 1993) (figure
1.5). The relative chemopreventive efficiencies for the various compounds are as 
follows (Ip and Ganther, 1988,1990; Ip et al., 1991):
SB = SBME = SMSC >Selenite > DMS > TMS+
The chemopreventive activities of these varioiPS compounds could be 
markedly affected when co-administered with arsenite. Interestingly, the effect of 
selenite was found to be diminished by arsenite whereas tthe effect of SB, SBME, 
SMSC and TMS+ were enhanced (Ip and Ganther, 19888, 1990; Ip et al., 1991). 
This observation, together with the fact that (1) sselenite enters selenium 
metabolism prior to H2 Se formation whereas the other ccPmpounds enter selenium 
metabolism after H2 Se methylation and (2) in cell-free systems, H2 Se methylation 
is sensitive to inhibition by arsenite (Hsieh and Ganther, 1977), suggested that a 
methylated selenium compound may be responsible for thee chemopreventive effect 
of selenium (figure 1.5). Analysis by high pressure liqquid chromatography of 
selenium excretory products resulting from oral feedirg (Of all six compounds at 
chemopreventive doses revealed that the mono-, di- andtni-methylated compounds 
resulted in higher levels of excreted methylated metabclitres compared to selenite 
feeding and that this reflected their expected entry point intito intermediary selenium 
metabolism (figure 1.5) (Vadhanavikit et al., 1993). Hcwe'ever, there was rt> clear 
correlation between the levels or form of excreted metiylaated metabolites and the 
chemopreventive efficacy of the various compounds adcfed 1 to the diet. Moreover, 
arsenite had no significant effect on the profile of excrefed 1 methylated metabolites 
for any of the seleno-compounds (Vadhanavikit et al., 1)92*3). Thus, it is presently 
unclear why arsenite has differential effects on the chimflopreventive activity of 
selenite and other methylated seleno-compounds. Hove^ver, the data presently
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Figure 1.5
Synthetic methylated selenium compounds and their point of entry into intermediary 
selenium metabolism.
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available suggests that arsenite does not alter selenium metabolism but could 
directly interact with seleno-metabolites.
Another important factor determining the efficacy of selenium to act as an 
anti-carcinogen in the DMBA-induced mammary model appears to be the 
bioavailability of the selenium atom for incorporation into selenoproteins such as 
GPX. In GPX activity repletion assays, in which selenium compounds are tested 
for their ability to restore GPX activity in selenium deficient animals, the selenium 
in active chemopreventive compounds such as selenite, TMS+, SMSC, DMS, 
Brazil nut-derived selenium and p-XSC  can be incorporated into GPX (Ip et al., 
1991; Reddy et al., 1992; Ip and Lisk, 1994b; Ip and Ganther, 1992). In contrast, 
the selenium in ebselen (2-phenyl-l,2-benzisoselenazol-3-(2H)-one), which has no 
anti-carcinogenic activity, is metabolically inert and thus not available for 
incorporation into GPX (Ip et al., 1991). This could imply that selenium is acting 
through a selenoprotein. However, as is the case with tissue selenium levels, the 
extent to which a seleno-compound can restore GPX activity is not a good 
indicator of chemopreventive efficacy (Ip et al., 1991, see also section 2.4.2). 
Selenium may need to act through a seleno-compound which is generated from the 
metabolically available selenium pool which would imply that it is essential that 
selenium enter intermediary metabolic pathways to have a chemopreventive effect 
Biosynthesis of selenoproteins may therefore just be an indicator of the 
bioavailability of selenium in a particular compound but not necessarily be of any 
functional significance with respect to chemopreventive activity.
The chemopreventive efficacy of selenium is clearly dependent on a number 
of factors but exactly what these are is still unclear. However, the point of entry of 
a particular selenium compound into intermediary metabolism and to some extent 
nutritional bioavailability are evidently important constraints on the 
chemopreventive effects of selenium. Furthermore, these factors may differ for 
different tumour models. For example, selenium administered as selenite and 
p-XSC at a dietary level of 2.5 and 5ppm, respectively, is equally effective at
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inhibiting DMBA-induced mammary tumours (Ip et al., 1994b). However, 4- 
(methylnitrosamino)-l-(3-pyridyl)-l-butanone-induced mouse lung tumours are 
refractory to the effect of 5ppm selenium administered as selenite but are sensitive 
to 5ppm selenium administered as p-XSC  (El-Bayoumy et al., 1993). This 
suggests that different selenium compounds may be active against different 
pathways of tumour progression.
2.4 Anticarcinogenic effects of selenium: Possible mechanisms
The mechanism of selenium-induced inhibition of carcinogenesis is 
unknown. Any hypothesis must take into account the ability of selenium to inhibit 
tumours at a number of different sites, that selenium can inhibit tumours induced 
by a wide range of chemical and viral agents that have different modes of action 
and that selenium is active at both initiation and promotion, two mechanistically 
distinct stages of carcinogenesis. The most likely explanation is that selenium 
inhibits tumorigenesis by a number of mechanisms. A number of postulated 
mechanisms as to how selenium inhibits tumorigenesis are briefly covered in the 
following sections.
2.4.1 Alteration of carcinogen metabolism
The ability of selenium to act during the initiation stage of a number of 
chemical-induced tumours suggests that selenium somehow inhibits mutagenic 
events. Indeed, in micro-organisms, selenium has been demonstrated to be 
protective against both spontaneous (Rosin, 1981) and chemical-induced mutations 
caused by a variety of agents such as malondialdehyde (MDA), (3-propiolactone 
(Shamberger et al., 1979), acetylamino fluorene (AAF) (Jacobs et al., 1977), 
acridine orange, DMBA (Martin et al., 1981) and
N-alkyl-N'-nitro-N-nitrosoguanidine (MNNG) (Rosin and Stich, 1979).
Carcinogen metabolism, involving activation and detoxification reactions, is 
critical in modifying the mutagenicity of certain carcinogens. Carcinogen
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metabolism involves two classes of enzymes, termed phase I and phase II enzymes. 
Phase I enzymes, which include the microsomal monooxygenase system and P-450 
cytochrome oxidases, introduce polar groups onto xenobiotics, such as drugs, 
poisons and carcinogens (Guengerich, 1988). The reactions are on the whole 
oxidations but also include some reductions (Guengerich, 1991). While these 
reactions are largely protective for the cell by facilitating detoxification of the 
xenobiotic, many pro-carcinogens are activated by phase I enzymes (Guengerich, 
1988). The ultimate carcinogenic forms are positively charged electrophilic 
species. The electrophilic nature of active carcinogens, either those that act 
direcdy or those activated by phase I enzymes, can induce phase II enzymes, which 
include glucuronyltransferase, NADP(H):quinone reductase and a family of 
glutathione 5-transferases (GSTs) (Prochaska and Talalay, 1988). Phase II 
reactions involve conjugations resulting in the formation of glucuronides, GSH 
conjugates and sulphates which are excreted (Wattenberg, 1985).
Many chemopreventive compounds are thought to act by modifying levels 
of phase I and phase II enzymes and thereby inhibit activation or increase 
detoxification of carcinogens (Wattenberg, 1983, 1992; Zhang and Talalay, 1994; 
Yang et al., 1994). Evidence suggests that the chemopreventive effects of 
selenium could involve similar mechanisms. For example, the activity of the phase 
I enzyme, aryl hydrocarbon hydroxylase, can be inhibited by selenium in cultures of 
human lymphocytes (Rasco et al., 1977). Additionally, when rats were fed the 
liver carcinogen, A-hydroxy-2-acetylaminofluorene (NOHAAF), selenium 
supplementation was shown to increase the hepatic activities of the phase II 
enzyme, glucuronyltransferase and inhibit the activity of 
p-nitrophenyl-sulphotransferase, the enzyme responsible for producing the ultimate 
carcinogenic metabolite of NOHAAF (Daoud and Griffin, 1978; DeBaun et al., 
1970). This shift in NOHAAF metabolism favouring detoxification was reflected 
by a decrease in the amount of hepatic NOHAAF and reduction in the amount of 
liver DNA-bound carcinogen (Daoud and Griffin, 1978). The effect on
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NOHAAF-DNA binding appeared quite specific since AAF-DNA adduct 
formation was unaffected by selenium supplementation (Daoud and Griffin, 1978).
Other indirect evidence for the effect of selenium on carcinogen metabolism 
has been shown for 1,2-dimethylhydrazine (DMH). Selenium supplemented rats 
fed [14C]DMH, were found to exhale larger amounts of [ ^ CJazomethane, a 
pro-carcinogenic metabolite of DMH, than control rats on low selenium diets 
(Harbach and Swenberg, 1981). Again, this was reflected in a lower amount of 
liver DNA alkylation products (Harbach and Swenberg, 1981).
The formation of DMBA-DNA adducts in mammaiy tissue is also 
reduced in selenium supplemented rats (Ip et al., 1995; Liu et al., 1991). 
Additionally, DMBA-DNA adduct formation is reduced in mammary epithelial 
cells cultured in supplemental selenium or in mammaiy epithelial cells derived from 
rats fed high selenium diets as compared to the unsupplemented control cells and 
rats, respectively (Ejadi et al., 1989). This suggests that increased carcinogen 
detoxification may occur in the target organ and not necessarily require systemic 
detoxification by, say, the liver.
Inhibition of mutagenic events may also be achieved by increased repair of 
mutagenic lesions. In rats fed AAF, hepatic AAF-DNA adduct formation was 
unaffected by supplemental selenium in the diet, in agreement with the findings of 
Daoud and Griffin (1978), suggesting that AAF metabolism was unaltered 
(Wortzman et al., 1980). However, AAF was found to induce single strand DNA 
breaks. This occurred to a greater degree in rats on a low selenium diet as 
compared to rats on a selenium supplemented diet suggesting that although AAF 
metabolism was unaltered, AAF-induced single strand DNA breaks were repaired 
more efficiently in selenium supplemented rats (Wortzman et al., 1980).
2.4.2 Inhibition of oxidative damage by production of glutathione peroxidase
Cells are constantly exposed to reactive oxygen species and their harmful 
effects. Activated oxygen species may arise endogenously as a result of oxidative
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phosphorylation. Although this is a very efficient process, -2% of the oxygen 
becomes uncoupled from the mitochondrial respiratory chain resulting in partially 
reduced oxygen (Chance et al., 1979). Other endogenous sources include 
peroxisomes (Kassai et al., 1989) and cytosolic oxidases (Kehrer and Smith,
1994). The most common activated oxygen species are superoxide anion and 
hydrogen peroxide. These can further react together with a metal catalyst, such as 
ferric or cupric ions, to generate the highly reactive hydroxyl radical by the 
Haber-Weiss reaction (figure 1.6). The consequence of reactive oxygen species 
generation is oxidative damage to DNA and proteins (Frei, 1994). Additionally, 
reactive oxygen species may cause the auto-oxidation of polyunsaturated fatty 
acids, which is termed lipid peroxidation (Logani and Davies, 1980). This type of 
oxidation is initiated by allylic hydrogen abstraction followed by oxygen attack on 
the carbon radical thus generated. The lipid peroxyl radical can then react with an 
adjacent polyusaturated fatty acid side chain to form another lipid radical (figure
1.6). The self-propagating nature of lipid peroxidation means that, uncontrolled, 
lipid peroxidation can be very detrimental to the cell resulting in the production of 
toxic by-products and loss of membrane conformation and structural integrity 
(Kappus and Sies, 1981).
There is strong evidence for the role of oxygen free radicals in 
carcinogenesis (Sun, 1990). Indeed, many carcinogens participate in redox cycling 
which generate reactive oxygen species (ROS) (Kappus and Sies, 1981). Cells 
have thus evolved a battery of antioxidant enzymes to protect against the 
generation and effects of ROS. Superoxide dismutases dismute superoxide to 
hydrogen peroxide and catalase reduces hydrogen peroxide to water (figure 1.6) 
(Frei, 1994). The family of GPXs also reduce hydrogen peroxide, in addition to 
various organic and lipid hydroperoxides (figure 1.6). The discovery that selenium 
formed an integral part of GPX (Rotruck et al., 1973) thus provided a possible 
mechanism for the chemopreventive activity of selenium. According to this 
hypothesis, selenium could act in an antioxidant manner by increasing the levels of
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2GSH GSSG
SOD GPXs
Fe + HO~+ HO
Haber-Weiss Reaction
B
RH + 0 2 --------► R + HO
R + 0 2 --------► ROO
ROO + R H  ► ROOH + R
R + R  ► RR
R + ROO  ► ROOR
ROO + ROO --------► ROOR + 0 2
Figure 1.6
(A) Schematic representation of some of the reactions leading to the production of 
reactive oxygen species and their subsequent detoxification by antioxidant enzymes
(B) Lipid peroxidation: RH represents a fat molecule in which H is an allylic 
hydrogen
(see text for more details)
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GPX and thus reduce the levels of peroxides and subsequent DNA damage and 
lipid peroxidation which is also believed to play a role in carcinogenesis (Cerutti,
1985). Evidence suggested that the chemopreventive activity of selenium could be 
mediated through an antioxidant function. The incidence of DMBA-induced 
mammary tumours in rats increases under conditions of selenium-deficiency (Ip 
and Sinha, 1981a). However, this augmentation is only apparent in animals on a 
high polyunsaturated diet and not in rats on a low polyunsaturated fat or high 
saturated fat diet suggesting that the tumour-enhancing effect of 
selenium-deficiency may involve increased lipid peroxidation (Ip and Sinha, 
1981a). Additionally, vitamin E, with known antioxidant functions, did not have 
an inhibitory effect on DMBA-induced mammary tumours when administered 
alone but could synergize and enhance the anti-carcinogenic effect of selenite, 
further suggesting an antioxidant role in the chemopreventive effect of selenium 
(Horvath and Ip, 1983). However, the chemoprotective effect of supra-nutritional 
levels of selenium-supplementation in the DMBA-induced mammary tumour model 
is independent of the level and type of fat in the diet with selenium having a 
protective effect in rats fed low or high polyunsaturated fat and high saturated fat 
diets (Ip and Sinha, 1981b). Additionally, the levels of malondialdehyde (MDA), a 
marker of lipid peroxidation, was unaffected by selenium-supplementation, 
suggesting that selenium does not act by reducing lipid peroxidation (Ip and Sinha, 
1981b). Lane and Medina (1983) also demonstrated that mammary and liver GPX 
was maximally active at dietary levels of selenium that are ~20-fold lower than the 
minimum dose required for a chemopreventive effect in DMBA-induced mammary 
tumours. Additionally, as mentioned above, although GPX activity is generally 
dependent on dietary levels of selenium, the extent to which different 
anti-carcinogenic selenium compounds can restore GPX activity in 
selenium-deficient animals is not necessarily a reliable indicator of chemopreventive 
efficacy in the DMBA-induced mammaiy tumour model (Ip et al., 1991). These 
findings suggest that selenium does not act through the activation of GPX and
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subsequent reduction in lipid peroxidation in the DMBA-induced mammary tumour 
model. However, the role of other GPX family members in the anti-carcinogenic 
effects of selenium is relatively unexplored. For example, PHGPX, which is 
ubiquitously expressed, has a broader substrate specificity than GPX and therefore 
may detoxify hydroperoxides critical in carcinogenesis that are not substrates for 
GPX. This would require that selenium be differentially channelled into the 
synthesis of these two enzymes. Indeed, in selenium-deficient animals, PHGPX 
and GPX activities are differentially maintained suggesting that the supply of 
selenium to these two enzymes is different (Weitzel et al., 1990).
Nevertheless, GPX activity could play a role in different, non-mammary, 
tumour models. For example, while GPX activity in the liver and mammary tissue 
is saturated at 0.1 ppm selenite in the diet (Lane and Medina, 1983), colon GPX 
activity in azoxymethane-treated rats could be further increased (~3-fold) by 
supplementation with 20ppm p-XSC  in the diet (Reddy et al., 1992). This 
correlated with a 21% inhibition in the incidence of azoxymethane-induced colon 
tumours (Reddy et al., 1992).
2.4.3 Inhibition of cell proliferation
While selenium may be able to inhibit the mutagenic events of tumour 
initiation, the ability of selenium to inhibit post-initiation stages of tumorigenesis 
suggests that selenium somehow inhibits the growth of initiated tumour cells. This 
could be achieved systemically by, say, stimulation of the immune system which 
has been reported for selenium supplementation (Kiremidjian-Schumacher and 
Stotzky, 1987). However, selenium can inhibit the formation of nodule-like 
alveolar lesions in mammary gland organ culture (Chatteijee and Baneijee, 1982) 
and inhibit UV-induced skin lesions and tumours when applied topically (Burke et 
al., 1982) suggesting that selenium may act directly on cells.
In vitro, selenium is also an essential trace element and is required for the 
maximum growth of cells (McKeehan et al., 1976; Medina and Obom, 1981).
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However, at higher concentrations, selenium is a potent inhibitor of cell growth 
and, similar to the in vivo situation, the growth suppressing effect is highly 
dependent on chemical form (Fico et al., 1986; Yan et al., 1991). In vitro, the 
most commonly used form is selenite, which is both anti-carcinogenic and 
anti-proliferative. Intracellularly, selenite is reduced by GSH to H2 Se (Hsieh and 
Ganther, 1977) (Figure 1.1). It is thought that for selenite to exert it's effect it 
must undergo this metabolic reduction since the simultaneous addition of GSH can 
enhance the growth suppressing effect of selenite (Yan et al., 1991; Kuchan and 
Miller, 1991). Furthermore, SDG, the primary product from the reaction between 
selenite and GSH (Figure 1.1) is a potent inhibitor of cell growth and is more 
effective than selenite (Fico et al., 1986).
The mechanism by which selenite acts as an anti-proliferative agent is 
unclear. Selenite has been shown to have a number of biological effects such as 
inhibiting protein kinase C (Su et al., 1986), which is believed to be an effector of 
various tumour promotors such as 12-0-tetradecanoyl phorbol-13-acetate (TPA). 
Additionally, c-myc, which is thought to regulate a number of genes involved in 
cell proliferation, including ornithine decarboxylase (Bello-Femandez et al., 1993) 
and a-prothymosin (Gaubatz et al., 1994), is down regulated by selenite both in 
vitro and in vivo (Yu et al., 1990).
Selenium is also an inhibitor of DNA, RNA and protein synthesis 
(Gruenwedel and Cruikshank, 1979) and has been shown to inhibit the activity of a 
number of enzymes involved in all three processes. Thymidine kinase activity can 
be inhibited in cultured cells and in cell-extracts selenium has been shown to inhibit 
the activity of DNA methylase, DNA polymerase a  and RNA polymerase II 
(Tillotson et al., 1994; Cox and Goorha, 1986; Frenkel et al., 1987). Additionally, 
in cell-free assays, selenite and SDG are potent oxidants of the thioredoxin system 
(Bjomstedt et al., 1992; Kumar et al., 1992) which acts as a hydrogen donor for 
ribonucleotide reductase (Holmgren 1985). SDG is also a potent inhibitor of 
protein synthesis in cell-free systems and in intact cells (Vemie et al., 1983) and it
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has been shown to inhibit mammalian elongation factor 2 (Vemie et al., 1975) and 
initiation factor 2 (Safer et al., 1980). While it is apparent that selenium can 
directly inhibit the synthesis of DNA, RNA and protein synthesis, it is unclear what 
functional significance this has for the growth inhibitory effects of selenium. For 
example, Fico et al. (1986) have demonstrated that the inhibition of RNA 
synthesis, but not DNA or protein synthesis, correlates with selenium-induced 
growth suppression.
Selenium has also been shown to affect progression through the cell cycle. 
In cultured hepatoma cells, flow cytometry analysis indicated that selenite 
increased the proportion of cells in G1 of the cell cycle and increased cell doubling 
time (LeBoeuf et al., 1985). From the doubling time and proportion of cells in 
various phases of the cell cycle, the duration of each phase could be calculated and 
selenite was found to increase the length of G l, S and G2, but not M, of the cell 
cycle (LeBoeuf et al., 1985). However, this may be a cell-type specific effect, 
since in cultured mammary cells, flow cytometry analysis showed selenite induced 
a specific block in S-G2 of the cell cycle (Medina et al., 1983).
2.4.4 Activation of apoptosis and possible involvement of oxidative stress
Cancer occurs due to a loss in tissue homeostasis such that there is a net 
gain in cell number. This may be accomplished by an increase in proliferation. 
However, it is becoming increasingly clear that cell death plays an important role in 
tissue homeostasis and that cancer may arise due to an imbalance of cell division 
and cell death.
Apoptosis is a genetically programmed, delineated set of events that lead to 
cell death which can be induced by a variety of physical and chemical treatments 
such as irradiation, growth factor withdrawal and exposure to a number of 
anti-neoplastic drugs (Barry et al., 1990; Williams et al., 1990; Warters, 1992). 
Characteristic features include chromatin condensation, fragmentation of the 
nucleus and convolution of the cell membrane (Wyllie, 1985). Chromatin
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condensation is believed to result from the cleavage of genomic DNA into 
600-50Kb or smaller polynucleosomal fragments (Wyllie, 1985; Oberhammer et 
al., 1993; Bicknell et al., 1994). The final stages of apoptosis involve the 
"pinching" off of cell contents in membrane encapsulated apoptotic bodies (Wyllie,
1985). This is in contrast to necrosis, where the cell membrane is ruptured and the 
cells contents are released into the extracellular environment
Apoptosis is an active process as exemplified by the fact that some cells 
require protein synthesis to initiate apoptosis (Story et al., 1992). Genetic 
approaches designed to identify genes involved in regulating apoptosis have been 
most informative in the nematode worm, Caernorhabditis elegans. During its 
development, certain cells are programmed to die by apoptosis. This has been 
shown to require the activity of two genes, ced3 and ced-4 (Ellis and Horvitz,
1986), whereas a third gene product, ced-9, inhibits apoptosis (Hengartner et al., 
1992). Mammalian homologues of ced-3 and ced-9 have been identified 
suggesting that apoptosis is evolutionary conserved. The mammalian ced-3 
homologue encodes interleukin-lp (II- lp) converting enzyme (ICE) and is 
involved in processing of the growth-factor II-lp (Yuan et al., 1993). Both Ced-3 
and murine ICE can induce apoptosis when transfected into rat fibroblasts 
demonstrating functional as well as structural conservation (Miura et al., 1993). 
The mammalian protein, Bcl-2, the homologue of ced-9, can substitute functionally 
for Ced-9 in C. elegans (Hengartner and Horvitz, 1994) and it also inhibits 
apoptosis in mammalian cells induced by a variety of chemical treatments (Zhong 
et al., 1993). Bcl-2, which is localised in membranes (Hockenberry et al., 1990), 
has no defined biochemical function. However, it has been postulated to have 
antioxidant activity since overexpression of Bcl-2 in T-cells has been shown to 
inhibit dexamethasone-induced lipid peroxidation (Hockenberry et al., 1993). A 
number of other bcl-2-like genes have also been identified (Boise et al., 1993; 
Kozopas et al., 1993; Lin et al., 1993; Oltvai et al., 1993). Of particular interest 
are box and bcl-x, the functions of which have been studied in a B-cell line which
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upon withdrawal of the cytokine 11-3 undergoes an apoptosis that is prevented by 
Bcl-2 overexpression. Bax can heterodimerise and inhibit the protective function 
of Bcl-2 (Oltvai et al., 1993). bcl-x encodes a transcript that is differentially 
spliced to give two mRNAs, Bc1-xl and Bcl-xg. Bc1-xl has similar 
anti-apoptotic activity to Bcl-2 whereas Bcl-xg has no effect on apoptosis 
induction when overexpressed alone but can antagonise Bcl-2 function when 
co-expressed in a Bcl-2 expressing cell line (Boise et al.> 1993). The existence of a 
number of apoptosis-regulating genes that have been evolutionary conserved 
demonstrates that programmed cell death is an important process in multi-cellular 
organisms for the removal of unwanted cells which is subject to a complex control 
involving multiple pathways and gene products.
If the anti-carcinogenic effects of selenium involve the inhibition of cell 
proliferation, one way this could be achieved could be through the activation of 
apoptosis. Indeed, both organic and inorganic seleno-compounds have been 
shown to induce apoptosis in diverse systems such as leukaemia and mammary 
cultured cells as judged by morphological criteria, formation of nucleosomal 
ladders and flow cytometry, which utilises the principle of differential uptake of 
two DNA-binding fluorochromes by apoptotic but not necrotic cells (Lanfear et 
al., 1994; Lu et al., 1994; Thompson et al., 1994). The mechanism of induction is 
unknown; however oxidative stress has been postulated to be involved since the 
generation of reactive oxygen species, superoxide anion and hydrogen peroxide, 
have been shown to be generated from the reaction of selenite and thiols using the 
chemiluminescent compounds lucigenin and luminol (Yan and Spallholz, 1993). 
This is consistent with selenite's requirement for GSH to mediate its 
growth-inhibitory effect. Moreover, selenite-induced DNA strand breaks have 
been shown to be oxygen-dependent (Garberg et al., 1988). Selenite can also 
deplete GSH stores (Anundi, et al., 1984), which may also contribute to a 
pro-oxidant state.
40
Generally, oxidative stress is believed to play a causative role in apoptosis 
(Buttke and Sandstrom, 1994). Neurons when cultured in a high oxygen 
atmosphere undergo apoptosis (Enokido and Hatanaka, 1993). Similarly, 
hydrogen peroxide can induce apoptosis in a variety of cell systems as judged by 
morphological criteria and the formation of nucleosomal DNA ladders (Pierce et 
al., 1991; Forrest et al., 1994). Consistent with this, antioxidants such as 
jV-acetylcysteine and GSH can block apoptosis induced by a variety of signals such 
as growth factor withdrawal (Hockenberry et al., 1993), the endotoxin 
lipopolysaccharide (Abello et al., 1994) and T-cell receptor activation (Sandstrom 
et al., 1994). Additionally, overexpression of the antioxidant enzyme GPX inhibits 
H-3 deprivation-induced apoptosis (Hockenberry et al., 1993).
2£  Aims of project
The broad aims of this project are to investigate the molecular mechanisms 
by which selenium inhibits cell growth in vitro since similar mechanisms may 
account for some of the chemopreventive effects of selenium. A mouse mammary 
cell line, C57, has been used in these studies since the chemopreventive effects of 
selenium have been most extensively characterised in mammary tumour models. A 
number of approaches have been adopted. Since the in vivo effects of selenium are 
highly dependent on chemical form, the response of C57 cells to various selenium 
compounds with varying degrees of chemopreventive activity has been assessed. 
Regarding possible mechanisms of growth inhibition, the strong link between 
selenium metabolism, oxidative stress and the induction of apoptosis has been 
investigated. Also, a genetic approach has been taken using an SDG-resistant 
variant to identify other and possibly novel mechanisms of growth inhibition 
induced by selenium.
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Chapter 3 
Materials and Methods
3.1 Materials
3.1.1 Cell lines, media and tissue culture supplies
Mouse mammary epithelial cell line, C57, had been previously derived 
(Vaidya et a l 1978). NRK49 fibroblasts were from laboratory stocks.
Supplier: Beatson Institute Central Services
- sterile dH2 0
- sterile PBS
- sterile glassware and glass pipettes
Supplier: Becton Dickinson Labware, Plymouth, U.K.
- 60mm and 1 0 0 mm diameter tissue culture dishes
Supplier: Fisons Scientific Equipment, Loughborough, Leics., UK.
- dimethylsulphoxide (DMSO)
Supplier: Gibco Europe Life Technologies Ltd., Paisley, UK.
- Eagle's minimal essential medium
- Foetal calf serum (FCS)
- 200mM glutamine
- 1MHEPES
Supplier: A/S Nunc, Roskilde, Denmark
- Tissue culture flasks
- Nunc tubes
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Supplier: Worthington, New Jersey, USA
- trypsin
3.1.2 Chemicals
Supplier: Amersham International pic, Amersham, Bucks., U.K.
-[oc-32p] dCTP ~ 3mCi/mmol
Supplier: BDH Chemicals Ltd., Poole, Dorset, UK.
Unless otherwise stated, all chemicals were obtained from BDH and were of 
AnalaR grade or better.
Supplier: Bethesda Research Laboratories, Life Technologies, Inc., USA
- agarose, ultrapure electrophoresis grade
- LMP agarose, ultrapure electrophoresis grade
Supplier: James Burrough Ltd., Witham, Essex, UK.
- ethanol
Supplier: DuPont UK Ltd., Stevenage, Herts., UK.
- 3 5 S-GSH
Supplier: Fisons Scientific Equipment, Loughborough, UK.
- acetic acid
- chloroform
- 38% (w/v) formaldehyde
- glycerol
-hyperchloric acid (HCIO4 )
- methanol
- propan-2 -ol
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Supplier: Fluka Chemika-Biochemika AG, Buchs, Switzerland
- formamide
Supplier: Merck, Darmstadt, Germany
- ninhydrin
Supplier: Millipore UK Ltd., Watford, Herts., U.K.
- all reagents for 2D gel electrophoresis
Supplier: National Diagnostics, Manville, New Jersey, USA
- ecoscint A
Supplier: Pharmacia Ltd., milton Keynes, Bucks., U.K.
- 50mM dNTPs
- Sephadex G-50
- Sephadex G-100
Supplier: Pierce and Warringer, Chester, U.K.
- Coomassie protein assay reagent
Supplier: Rathburn Chemicals Ltd., Wakeburn, U.K.
- phenol
Supplier: Sigma Chemical Co., Ltd., Poole, Dorset, U.K.
- bromophenol blue
- bovine serum albumin (BSA) (fraction V)
- ethidium bromide
- ethylmethanesulphonate (EMS)
- 4,6-diamidino-2-phenylindole (DAPI)
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- Dowex-50 Na+ resin
- DTNB
- Giemsa
- reduced glutathione (GSH)
- oxidized glutathione (GSSG)
- Hoechst 33258 
-MOPS
- nickel chloride
- polyvinylpyrolidone
- salmon sperm DNA
- selenomethionine ([Se]Met)
- sodium selenite 
-TEMED
- triton X-100
Supplier: Surgipath, St. Neots, Cambridgeshire, U.K.
- hematoxylin
- eosin
- scots tap water
Supplier: University o f Missouri, Columbia, USA
- [7 5 Se]-sodium selenite ~430|iCi/pg Se
Supplier: Vector Labs Inc., Burlingame, California, USA
- Vectashield
3.1.3 Enzymes and Inhibitors
Supplier: Boehringer Corporation (London) Ltd., Lewes, East Sussex, U.K. 
- Klenow
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- MoMuLV reverse transcriptase
- Proteinase K
Supplier: Promega, Southhampton, Hampshire, U.K.
- Taq DNA polymerase + reaction buffer
- RNASin
Supplier: Sigma Chemical Co., Ltd., Poole, Dorset, U.K.
- glutathione reductase
3.1.4 Kits
Supplier: Bio 101 Inc., Stratatech Scientific, Luton, U.K.
- Geneclean kit
Supplier: Appied Biosystems, Warrington, U.K.
- Dyedeoxy Terminator Cycle Sequencing Prism Kit
Supplier: Boehringer Manheim UK, Lewes, East Sussex, U.K.
- DNA random priming labelling kit
Supplier: Gibco Europe Life Technologies Ltd., Paisley, U.K.
- Trizol
3.1.5 Markers
Supplier: Bethesda Laboratories Research, Gibco Ltd., Paisley, U.K.
- kb DNA ladder
- RNA ladder
- X phage DNA
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Supplier: Bio-RAD , Hemel Hempstead, Herts., UK.
- yeast chromosome markers
3.1.6 Membranes, paper, TLC plates and X-ray film 
Supplier: Amersham international pic, Amersham Bucks., UK.
- Hybond N+
Supplier: Eastman Kodak Co., Rochester, New York, USA 
-X-ray film (XAR)
Supplier: Camlab Ltd., Cambridge, U.K.
- Polygram TLC plates
Supplier: Whatman International Ltd., Maidstone, Kent, UK.
- 3MM chromatography paper
3.1.7 Water
Distilled water for buffers and all general solutions were purified through a 
Millipore MillRO 15 system. Water for protein of nucleic acid procedures which 
required further purification was obtained from a Millipore MilliQ system at 18MQ 
cm.
3.2 Methods
3.2.1 Tissue culture
All cell lines were grown in Eagle’s minimal essential medium supplemented 
with 10% foetal calf serum (FCS), ImM glutamine and ImM HEPES buffer. Cells 
were kept in a moist atmosphere containing 5% CO2  (v/v) at 37°C. Cells were 
passaged at sub-confluency by rinsing with phosphate buffered saline (PBS) and 
removing cells from flasks with trypsin (lmg/ml PBS). Trypsin was inactivated by
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10% FCS and the cell suspension was diluted as required and seeded into fresh 
culture medium.
To reduce chances of genetic drift, cells were replaced from frozen stocks 
at least every 3 months. Frozen stocks were made from logarithmically growing 
cells in culture medium with 10% dimethyl sulphoxide (DMSO) added. Ampoules 
were slowly cooled to -70°C o/n by wrapping in cotton wool. Ampoules were 
then transferred to liquid nitrogen for long term storage. When required, cells 
were thawed rapidly at 37°C. DMSO was removed by centrifugation at 1000 rpm, 
5 min, and resuspension in fresh culture medium and cells were then transferred to 
flasks for routine culture.
3.2.2 Mycoplasma testing of cell lines
Cells were checked for mycoplasma contamination. Conditioned medium 
was collected from cells which had been cultured for at least 2-3d. ~2 ml of the 
conditioned medium was co-incubated with 2 x 10^ NRK49 fibroblasts in 2ml 
fresh culture medium. NRK49 fibroblasts are known to be mycoplasma-free 
although a negative control was always set up in parallel: NRK49 cells without 
conditioned medium. After incubation in a moist atmosphere containing 5% CO2  
(v/v) at 37°C for 3d, cells were fixed by the addition of fixative (1 volume glacial 
acetic acid: 3 volumes methanol) for 5min. This was followed with a further two 
incubations in fresh fixative for 5min and the cells allowed to air-dry. Hoechst 
33258 is a fluorescent stain which detects DNA and was prepared from a lmg/ml 
stock by diluting 1:20 000 in PBS. This solution was added to the fixed cells and 
incubated at R/T for lOmin. After staining, excess stain was removed and cells 
washed twice with dH20, then viewed by fluorescent microscopy using a water 
immersion lens. Mycoplasma contamination was detected as fluorescence in the 
cytoplasm of NRK49 cells.
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3.2.3 Growth curves
~5 x 104  cells were seeded into 25cm^ flasks and allowed to adhere o/n. 
Fresh culture medium was added containing the test agent. At the indicated times, 
cell numbers were determined by rinsing cells with PBS and removing adherent 
cells with trypsin (lmg/ml PBS) to obtain a single cell suspension. These were 
then counted using a Coulter counter (Coulter Electronics, Ltd.). Alternatively, 
after rinsing cells with PBS, cell number was determined indirectly by lysing 
adherent cells in situ with 0.5-3 ml 0.1M NaOH. Nucleic acid concentration of cell 
lysates was then determined spectrophotometrically by measuring absorbance of 
cell lysates at 260nm. The spectrophotometer was calibrated with a 0.1M NaOH 
blank and samples were read in a quartz cuvette with a 1cm pathlength. This 
figure was assumed to be linearly proportional to cell number.
3.2.4 Clonogenic assays
Logarithmically growing cells were seeded into 6 cm diameter dishes at a 
concentration of 100 cells/dish and allowed to adhere o/n. Cells were then 
exposed to increasing concentrations of either SDG or H2 O2 . H2 O2  was removed 
after lh and replaced with fresh culture medium. SDG was left in the medium for 
the entire duration of the experiment unless otherwise stated. Plates were then 
incubated in a moist atmosphere containing 5% CO2  (v/v) at 37°C for 10-14d. 
Colonies were rinsed with PBS and fixed and stained with 0.6% Giemsa in 50% 
glycerol/50% methanol (v/v). Plates were rinsed in H2 O and Giemsa-stained 
colonies counted. The plating efficiency of untreated cells was usually in the range 
of 50-80%.
3.2.5 Cell staining
5 x 105 cells were seeded into 25cm^ flasks and allowed to adhere o/n. 
Cells were then treated with with varying concentrations of either SDG or H2 O2  
for the indicated times. Detached cells were pooled with adherent cells, that were
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removed by trypsinisation, and - 1 0 ^ cells were centrifuged onto microscope slides 
in a Cryo-Tek cytospin centrifuge (500 r.p.m. for 5min) (Miles Scientific). Cells 
Iwerethen fixed in methanol for 5min. Cells were then stained with DAPI at a 
concentration of 20ng/ml in Vectashield (Vector Laboratories) and viewed by 
fluorescent microscopy. Cells were stained with hematoxylin and eosin in the 
following way: Cells were re-hydrated by 30s sequential soaks in ethanol, 70% 
ethanol and H2 O and stained in hematoxylin for 4min. Hematoxylin (Surgipath) 
stain was rinsed off with H2 O before cells were immersed in scots tap water 
(Surgipath) for lmin, rinsed in H2 O and stained with eosin by five 0.5s dips. 
Eosin stain was then rinsed off with H2 O and cells were dehydrated by sequential 
30s soaks in 70% ethanol, twice in ethanol and finally xylene. Cells were viewed 
under light microscopy.
3.2.6 Derivation of SDG-resistant cell lines
3.2.6.1 Mutagenesis
Conditions for mutagenesis were determined by constructing an 
ethylmethanesulphonate (EMS) dose-response kill-curve. 10^ cells were seeded 
into 7 5 cm^ flasks and allowed to adhere o/n. Cells were then exposed to 
increasing concentrations of EMS in serum-free medium which was removed after 
2h and replaced with fresh culture medium containing 10% FCS. Cells were left to 
recover for 24h before being seeded into 6 cm diameter dishes at a concentration of 
100 cells/dish. Colonies were rinsed with PBS and fixed and stained with 0.6% 
Giemsa in 50% glycerol/50% methanol (v/v) for 15min. Plates were rinsed in H2 O 
and Giemsa-stained colonies counted. A concentration of 1.75 mg/ml EMS was 
chosen since this gave a survival rate of 2 0 %.
3.2.6.2 Selection of SDG-resistant cells
1-4 x 105 viable cells either after mutagenesis with 1.75 mg/ml EMS or 
untreated, were seeded into 10cm diameter Petri dishes. Cell viablilty was
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estimated from the plating efficiency (50-80%) and an assumed EMS kill of 80%. 
Cells were allowed to adhere o/n after which they were exposed to varying 
concentrations of SDG. Plates were then incubated in a moist atmosphere 
containing 5% CO2  (v/v) at 37°C for 10-14d. Colonies were located by 
microscopy and ring cloned into fresh culture medium without SDG and 
maintained in routine culture.
3.2.7 DNA methodologies
3.2.7.1 Agarose Gel Electrophoresis
DNA fragments were resolved according to apparent molecular weights on 
agarose gels. 1% (w/v) agarose was dissolved in lx TAE buffer (40mM tris 
acetate, 20mM sodium acetate, 2mM EDTA, pH7.4) and after microwaving, the 
solution was allowed to cool to ~50°C before the addition of ethidium bromide at a 
final concentration of 0.5|ig/ml. Gels were cast in the appropriate gel former and 
allowed to set at R/T. Samples for electrophoresis were mixed with sample 
loading buffer, to a final concentration of 1 x (10 x loading buffer 50% (v/v) 
glycerol, 0.4% (w/v)bromophenolblue in TE buffer), loaded into sample wells and 
electrophoresed in 1 x TAE buffer, kb ladder molecular weight markers were run 
in parallel (Gibco BRL). After electrophoresis, resolved DNA was visualised by 
UV transillumination and a permanent record kept as either a polaroid or 
photoimage.
3.2.7.2 Purification of DNA fragments from agarose gels
The appropriate band was exised from the gel with the aid of UV 
illumination. DNA fragments were recovered from agarose by the methods of 
"Genecleaning" or centrfiugation. The procedure of "Genecleaning" was according 
to the manufacturer's instructions. For centrifugation, the gel slice was cut up into 
smaller pieces and placed on top of a glass wool plug contained in a 0.5ml 
eppendorf tube. This 0.5ml tube was previously pierced at the base using a
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syringe needle. The plugged tube with the gel slice was then placed in a 1.5ml eppendorf 
tube and centrifuged for 5-10 min. at 5K, R/T in a benchtop microfuge. this 
resulted in the DNA being eluted from the agarose in the gel buffer and collected in 
the 1.5ml eppendorf tube. The agarose remained in the glass wool plug, the DNA 
was further purified by phenol/chloroform extraction and ethanol precipitation 
when necessary.
3.2.7.3 Spectrophotometric quantitation of DNA
Absorbance readings at 260nm and 280nm were taken of samples diluted in 
water in a quartz cuvette with a 1cm pathlength. The spectrophtometer was 
calibrated with a water blank. An absorbance of 1 at 260nm was taken to be 
equivalent to 50mg/ml DNA and A2 5 0 /A2 8 O ratio of 1.8 indicative of an 
essentially pure preparation of DNA.
3.2.7.4 Preparation and quantitation of oligonucleotides
Oligonucleotides were synthesised on an Applied Biosystems model 381A 
DNA synthesizer. 5' trityl groups were removed on the synthesizer before the 
oligonucleotide was eluted from the column in concentrated (29%) ammonia 
solution for 1.5h at room temperature. Oligonucleotides were deprotected by 
incubation in ammonia in a sealed glass vial o/n
at 55°C. This was followed by ethanol precipitation with extensive washing of the 
pellet with 70% ethanol to remove salt. Oligonucleotides were resuspended in 
water and quantified spectrophotometrically as in section 3.2.7.3. An A2 5 0  value 
of 1 was taken to equal 33fig/ml of oligonucleotide. A ratio of A2 6 0 /A2 8 0  was 
-1.8 when sufficiently purified.
3.2.7.5 Sequencing
DNA was sequenced using cycle sequencing. DNA PCR products were 
sequenced on both strands using the same primers used in the initial PCR reaction.
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3.2 pmoles of primer was added to approximately l|ig  DNA and the total volume 
made up to 10.5[il using dH2 0 . To this mixture was added 9.5(il of the Dyedeoxy 
Terminator Cycle Sequencing Prism Kit (Applied Bio-Systems). Reactions were 
carried out in a Perkin-Elmer 9600 thermal-cycler using 25 cycles of 96°C for 15s,
50°C for Is and |60°C for 4min. 80|il dH20 was added to the reaction mixture and was
extracted twice with phenol/chloroform/ctf^O (68:18:14). The DNA was then 
precipitated by adding 15|il 2M sodium acetate, pH 4.5 and 300|il ethanol to the 
final aqueous phase and incubated at -70°C for 15min. The DNA was pelleted by 
centrifugation at 35 000 rpm for 15min in a microfuge and washed in 0.5ml 70% 
ethanol. After allowing the pellet to air-dry, it was then redissolved in 3-4|il of 
loading buffer (1:5 dilution of : 5parts deionized formamide, 1 part 50mM EDTA 
containing 30mg/ml blue dextran). Running and analysis of sequencing gels was 
expertly performed by Robert McFarlane (Beatson Institute, Glasgow, U.K.) as 
follows: Samples were run on a 6 % polyacrylamide gel (made from a 40% stock 
[19:1 ratio of acrylamide:bis-acrylamide]) in 1 x TBE buffer using an ABI 373A 
DNA Sequencer (Applied Biosystems) at 30W for 12h. Gels were analysed using 
373A software version 1.2.1.
3.2.7.6 Pulsed-field gel electrophoresis
2  x 1 0 ^ cells were seeded into 75cm^ flasks and allowed to adhere o/n.
Cells were then exposed to either 8 |iM SDG or 1.3mM H2 O2 . At the indicated 
times, detached cells were pooled with adherent cells, which were removed by 
trypsinisation. Cells were washed three times in PBS by centrifugation at lOOOrpm 
for 5min and resuspension in PBS. The cell pellet was then resuspended in 50(0.1 
ice-cold L-buffer (0.1M EDTA, [pH 8.0], 0.01M tris.HCl [pH 7.6], 0.02M NaCl) 
and warmed to 55°C. The cell suspension was then mixed with an equal volume of 
2% (w/v) low melting-point agarose in L-buffer, which had previously been boiled 
by microwaving and then cooled to 55°C. The molten mixture was then pipetted 
into 100|il sample mould plugs (Bio-Rad) and allowed to set on ice. Agarose
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blocks were then transferred to 50 volumes of L-buffer containing 1 mg/ml 
proteinase K and \%  sarkosyl and incubated for 24h at 50°C. The original 
digestion mixture was then replaced with fresh digestion mixture and incubated for 
a further 24h at 50°C. Agarose blocks were then sliced into blocks containing 
approximately 10^ cells and set in 1% (w/v) agarose in TBE buffer (90mM 
tris-base, 90mM boric acid, 2mM EDTA, pH 8.0), which had previously been 
boiled by microwaving and cooled to 65°C, or transferred to 50mM EDTA for 
long-term storage at 4°C. Yeast chromosome DNA size markers (Bio-Rad) and X 
phage DNA (Gibco BRL) were loaded in parallel to samples. Electrophoresis was 
carried out in 0.5 x TBE buffer at 14°C for 16h using the CHEF-DR II pulsed-field 
gel elctrophoresis system (Bio-Rad).
3.2.8 RNA methodologies
3.2.8.1 RNA extraction, purification and quantitation
In preparations of RNA and handling of RNA, some precautionary steps 
were taken in order to avoid degradation by contaminating RNases. All 
manipulations were carried out wearing gloves, tubes and solutions were 
pre-cooled on ice, centrifugations carried out at 4°C and aerosol-resistant, DNase- 
and RNase-free tips were used for all manipulations.
RNA extraction and purification using Trizol (Gibco BRL) was carried out 
according to the manufacturer's instructions. The concentration of aqueous 
solutions of RNA was measured spectrophotometrically as in section 3.2.7.3. An 
A2 6 O value of 1 was taken to equal 40fig/ml RNA.
3.2.8.2 RNA electrophoresis
RNA samples (~20-80|ig) were added to 5 x sample volume of sample 
buffer (0.7ml formamide, 0.15ml 10 x MOPS buffer [10 x MOPS buffer: 200mM 
MOPS, 50mM sodium acetate, lOmM EDTA, pH7.0], 0.24ml formaldehyde, 
0.1ml H2 O, 0.1ml glycerol, o.05% (w/v) bromophenol blue). RNA samples were
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denatured at 65°C for 15min., chilled on ice for lOmin., followed with a brief 
microfuge. RNA ladder (Gibco BRL) molecular weight markers were run in 
parallel. Electrophoresis was performed in a 1% (w/v) agarose gel containing 
2.2M formaldehyde in 1 x MOPS buffer with recirculation using a peristaltic pump.
3.2.8.3 Northern transfer and hybridisation
Following electrophoresis, northern gels were washed for 30min in 20 x 
SSC (3M NaCl, 0.6M sodium citrate, pH 7.0) before capillary action transfer to 
Hybond N+ membrane. Transfer buffer was 20 x SSC, and transfer was allowed 
to proceed for a minimum of 16h. After transfer, the membrane was UV 
cross-linked. Lanes containing RNA markers were fixed in 0.5% acetic acid for 
5min and stained with 0.04% methylene blue in 0.5M sodium acetate, pH5.2.
Hybridization buffer (5 x SSPE [20 x SSPE: 3.6M NaCl, 0.2M sodium 
phosphate, 0.02M EDTA, pH8.3], 5 x Denhardts [50 x Denhardts: 1% (w/v) ficoll, 
1% (w/v) polyvinylpyrrolidone, 1% (w/v) bovine serum albumin (BSA)], 50% 
(v/v) formamide, 0.5% (w/v) sodium dodecyl sulphate), was supplemented with 
denatured, sonicated salmon sperm DNA to a final concentration of 215fig/ml and 
incubated with the membrane at 42°C for a minimum of 4h with constant rotation 
in a Hybaid oven. Following pre-hybridization, radioisotopically labelled probe 
was boiled for 5min, chilled on ice for 5min and added to the hybridization buffer. 
The membrane was subsequendy hybridized for a minimum of 16h at 42°C. After 
hybridization, the membrane was washed under increasingly stringent conditions 
with the following wash solutions:
15min at room temperature with 1 x SSC, 0.1% (w/v) SDS 
15min at 65°C with 1 x SSC, 0.1% (w/v) SDS 
15min at 65°C with 0.1 x SSC, 0.1% (w/v) SDS
The membrane was then exposed to X-ray film at -70°C for the required times.
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3.2.8.4 cDNA synthesis and polymerase chain reaction (RT/PCR)
cDNA was synthesised as follows: Reverse transcription was carried out in 
a 20fil volume containing 1 x PCR buffer (Promega), ImM dNTPS, 20U RNAsin 
(Promega), lOOpmoles oligo(dT) primer, RNA (l-3|ig) and 200U BRL MoMuLV 
reverse transcriptase. The reaction was incubated at R/T for lOmin and then 
heated to 95°C for 5min and chilled on ice to denature the reverse transcriptase. 
To the 20|il reaction mixture was added 80fil 1 x PCR buffer (Promega) 
containing ~l(ig of each primer and 1-2U Taq DNA polymerase. The reaction 
mixture was overiayed with lOOfil paraffin oil to prevent evaporation. Reaction 
conditions were 40 cycles of : 94°C for lmin, annealing at 60°C for lmin and 
extension at 72°C for lmin. This was followed by a final extension step of 72°C 
for 5min. Analysis of PCR products by agarose gel electrophoresis was as 
previously described in section 3.2.7.1. For amplifying sequences using DNA as a 
starting template, similar PCR conditions were employed using ~l(ig genomic 
DNA from human foreskin fibroblasts (kindly provided by Kevin Ryan, Beatson 
Institute, Glasgow, U.K.).
3.2.8.4.1 Oligonucleotide sequences for RT/PCR
Prepared as previously described in section 3.2.7.4
GST Ya:
5 ’ ATGGCCGGGAAGCCCGTGCTT 3'
5' CTGAATCTTGAAAGCCTTCCT 3'
TRX:
5 ’ AGTAGTCTCGAGGGCCCAAAATGGTGAAGCTGATCG 3'
5 ’ AG TAG T T C T AGAGG T AC CAT GAT T AGGAAT AT T C AG 3'
56
Bcl-x
5 ’ ATGTCTCAGAGCAACCGGGAG 3'
5' AAAGCTCTGATATGCTGTCCC 3'
3.2.8.S Radioisotopic labelling using random priming
Random priming probes for Northern analyses used the commercially 
available kit marketed by Boehringer Manheim. The protocol followed was 
according to the manufacturer's instructions, incorporating radioisotope [oc-32p] 
dCTP. Probes were seperated from unincorporated radioisotope by 
chromatography on G-50 sephadex columns in 1 x TE (lOmM tris-HCl, ImM 
EDTA, pH7.0), 0.1% SDS.
3.2.9 2D protein gels
18.5|iCi [^^Se]-selenite was added to logarithmically growing cells and 
incubated in a moist atmosphere containing 5% CO2  (v/v) at 37°C. Culture 
medium was removed, cells rinsed twice with PBS and lysed in 0.5ml lysis buffer 
(9.9M urea, 4% (v/v) NP-40, 2.2% (v/v) ampholytes pH 3-10/2D, lOOmM DTT). 
The 2D gels were expertly performed by Lyn McGarry (Beatson Institute, 
Glasgow, U.K.) as follows: first dimension gels contained: 9.5M urea, 2% (v/v) 
NP-40, 4.1% (v/v) acrylamide (from stock acrylamide solution containing 30.8% 
(w/v) acrylamide, 2.6% (w/v) bis-acrylamide), 2% (v/v) ampholytes pH3-10/"D 
and polymerised with 0.67% (w/v) ammonium persulphate. These gels were 
overlayed with: 0.5M urea, 0.2% (v/v) NP-40), 0.1% (v/v) ampholytes pH 
3-10/2D, 5mM DTT, 0.7M (3-mercaptoethanol, then prefocused to 2000V using a 
constant current of 110|iA per gel. Samples were then applied beneath the overlay 
buffer, each sample contained -25 OOOcpm in 50fil sample buffer. Focussing was 
carried out for 18000 volt-hours (17.5h at 1000V then 30min at 2000V), after 
which the gels were extruded into gel equilibration buffer (0.3M tris-base, 75mM 
tris-HCl, 3% (w/v) SDS, 50mM DTT, 0.001% (w/v) bromophenol blue) and
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allowed to equilibrate for 2 min. before being placed horizontally on the upper 
surface of a vertical SDS polyacrylamide gel (10% (v/v) acrylamide/bis-acrylamide 
(stock: 30.8%/1.6%), 0.37M tris pH 8 .8 , 0.1% (w/v) SDS and polymerised with 
0.05% (v/v) TEMED and 0.025% (w/v) ammonium persulphate). Electrophoresis 
was continued for ~4h at a constant power of 16W per gel. All 2D gel chemicals 
were supplied by Millipore (UK) Ltd. Gels were dried onto blotting paper under 
vacuum at 80°C for 2h and exposed to X-ray film at room temperature for ~70d.
3.2.10 Synthesis and purification of selenodiglutathione (SDG)
SDG was synthesised by mixing the following reactants: 4ml 0.1M GSH, 
lml 0.1M Na2 SeC>3 and 1ml H2 O. A trace amount of ^^S-GSH (9.5|il of a 1:10 
dilution of -^S-GSH [specific activity 501.9 Ci/mmol]) was also included in the reaction 
to enable the SDG to be monitored in subsequent purification steps. The reaction 
mixture was incubated for 30min at R/T.
3.2.10.1 Separation of SDG and GSSG
Separation of the reaction products, SDG and GSSG, was achieved by 
chromatography primarily according to the method of Ganther (1971). 
Approximately 500g Dowex-50 resin Na+ was washed by gentle agitation in CIH2 O 
until washes ran clear. The resin was then gently washed with 1M HC1 and rinsed 
with dH2 0  until the pH of the washes returned to 7. This was repeated using 1M 
NaOH. 150g of the Dowex-resin was set aside and used for the subsequent 
concentration of SDG (see section 3.2.10.2) and the remaining 350g Dowex-resin 
was finally washed in 0.1 M sodium acetate, pH4.7 and was saturated with NiCl2  
by suspension in 2 x volumes of 0.1 M sodium acetate, 0.3M NiCl2 , pH4.7. The 
suspension was poured into a 3cm diameter jacketed column and allowed to pack 
under gravity to a height of about 60cm and then equilibrated with running buffer 
(0.1M sodium acetate, 0.01M NiG2 , pH4.7). Running buffer was pulled through 
the column under a vacuum, set up by a peristaltic pump, at a rate of 2.5ml/min.
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The sample was loaded onto the column by way of a three-way valve which 
temporarily disconnected the buffer reservoir from the column without introducing 
air into the system. The A2 4 0  of column eluate was measured by a UVcord n, UV 
monitor (LKB) connected to a chart recorder before 2ml fractions were collected 
in an Ultrurac 2070, fraction collector (LKB). This gave an estimation of which 
fractions contained the SDG which eluted as the second A2 4 0  peak. 200|il 
aliquots from each of these fractions was then measured for 35 S-radioactivity to 
identify exacdy which fractions contained SDG. These were then pooled and 5M 
HC1 was added to give a final pH of < 3.
3.2.10.2 Concentration of SDG
150g washed Dowex-50 resin (see section 3.2.10.1) was poured into a 8 cm 
diameter column and allowed to pack under gravity. 0.1M formic acid was pulled 
through the column under vacuum, set up by a peristaltic pump, at a rate of 
2.5ml/min, until the A2 4 0  ° f  column eluate became constant. The SDG was 
then loaded gently onto the column with a Pasteur pipette ensuring the resin was 
not disturbed. The SDG was then run into the column; under the acidic conditions 
SDG becomes adsorbed to the resin matrix. The column was then washed through 
with excess 0.1M formic acid until the A2 4 0  of the column eluate became constant 
again. The SDG was then eluted with 0.1M ammonium acetate, pH5.6 and the 
fractions containing SDG were monitored as described in section 3.2.10.1.
3.2.10.3 Buffer change
The SDG was loaded onto a GlO-sephadex column using dH2 0  as a 
running buffer. The column eluate was pulled through the column under a 
vacuum, set up by a peristaltic pump, at a rate of 0.7ml/min. SDG-containing 
fractions were monitored as described in sections 3.2.10.1 and pooled. Acetic acid 
was then added to give a final concentration of lOmM and 5ml aliquots were 
stored at -20°C. The amount of SDG purified was estimated by measuring the
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35S -r a d io a c t iv i ty  recovered, after purification, assuming the initial reaction had 
gone to completion.
The entire process of SDG synthesis and purification was performed over a 
period of 2-3d. Between each chromatographic step, SDG was stored at 4°C to 
minimise degradation of SDG.
3.2.10.4 Analysis of SDG purity
The purity of SDG was finally confirmed using absorbance spectra and thin 
layer chromatography (TLC). The absorbance spectrum of SDG was measured 
over a range of 220-420nm using a quartz cuvette with a 1cm pathlength. The 
spectrophotometer was calibrated with a dH2 0  blank. For TLC, ~15|il SDG was 
spotted onto Polygram SIL G TLC plates (Camlab) and chromatographed in a 
2 :1 :1  mixture of butanol:acetic acid:H2 0  in an air-tight glass chamber that had 
been pre-equilibrated with the solvent buffer. Run in parallel to SDG was l|il of 
4mM GSH, l|il of 2mM GSSG and 3pl of a mixture of 13.3mM GSH and 3.3mM 
Na2 SeC>3 that had been incubated for 30min at R/T. Chromatography was 
continued until the buffer front reached the top of the TLC plate. The TLC plate 
was then allowed to dry and chromatography was repeated , again until the solvent 
buffer reached the top of the TLC plate. After drying, the TLC plate was stained 
with 0.2% ninhydrin in ethanol and developed for 5min at 80°C.
3.2.11 Measurement of selenium uptake
2  x 1 0 ^ cells were seeded into 25cm^ flasks and allowed to adhere o/n. 
13.5p.Ci [^5Se]-selenite (specific activity: 3.5pCi/pl) was added to the culture 
medium and cells were incubated at 37°C. At the indicated times, cells were 
washed three times in PBS and adherent cells were lysed in situ with 1ml 0.1M 
NaOH. 0.7ml of each cell lysate was then measured for 75se-radioactivity in a 
y-radiation counter.
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3.2.12Measurement of GSH concentration
GSH concentration was measured essentially using the method of Tietze 
(1969). Logarithmically growing cells were removed by trypsinisation and washed 
twice with PBS by centrifugation (lOOOrpm, 5min) and resuspension. The final cell 
pellet was resuspended inlml PBS and was centrifuged at 6000rpm for lmin. The 
PBS was removed and the cells were lysed in lml 1M HCIO4 , 2mM EDTA and 
centrifuged at 6000rpm for lmin. The cell lysate was retained and the pellet 
redissolved in lml 0.3M NaOH and assayed for protein concentration by mixing 
5|il of the redissolved protein with lml of coomassie protein assay reagent (Pierce 
and Warringer) diluted 1:2 with (IH2 O and measuring the A5 9 5 . Protein 
concentration was calculated from a standard curve, constructed previously, using 
known concentrations of bovine serum albumin. 0.5ml of the cell lysate was added 
to 0.36ml 2M KOH, 0.3M MOPS and centrifuged at 6000 rpm for lmin. 200[il of 
the supernatant was added to 700pl of 0.3mM NADPH dissolved in 125mM 
phosphate-EDTA buffer (125mM NaH2 P0 4 *2 H2 0 , 125mM Na2 HP0 4 -2 H2 0 , 
6.3mM EDTA, pH 7.5) and 100|il of 6 mM 5,5'-dithio-bis-(2-nitrobenzoic acid) 
(DTNB) dissolved in phosphate-EDTA buffer. Samples were equilibrated to 30°C 
and transferred to a plastic cuvette. lOfil glutathione reductase (8.5U/ml) was 
added and the reaction monitored in a spectrophotometer by measuring the change 
in A4 1 2  over a period of 60s. GSH concentration was calculated from a standard 
curve, constructed previously, using known concentrations of GSH dissolved in 
phosphate-EDTA buffer. Intracellular GSH concentration was then calculated and 
expressed as mg GSH/ g protein.
3.2.13 Quantitative analysis of autoradiographs
Autoradiographs were scanned by laser densitometer (Molecular 
Dynamics) and image analysis carried out using the PDQuest and Quantity 1 
software from Protein Databases Incorporated.
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3.2.14 Statistical analysis
The students f-test was used to determine statistical significance of data. 
For northern analyses, comparing relative levels of mRNA levels between C57 and 
B19 cells, the null hypothesis to be tested was that the ratio of B19/C57 for a 
particular mRNA is 1. This was calculated using:
X - L l
,=l/£
where,
x= the mean value of the B19/C57 ratio
s2= l/(n - l ){ s x2. i/n(Xx)2 } 
n= sample number
For all other tests, where absolute values were being compared, the null hypothesis 
tested is that the means are equal. This was tested using:
Xi - X2
t=
s d /n .+  l / n / 2
where,
x1= the mean B19 values 
x^= the mean C57 values 
nx= the number of B19 values 
1^ = the number of C57 values
2 5i(x-x/+5^(x-x/
s  -------------------------
n 1+n2-2
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Chapter 4 
Mechanisms of growth inhibition by selenium
4.1 Anti-proliferative potential of selenium compounds in vitro
The efficiency of selenium to act as an anti-carcinogen is highly dependent on 
the chemical form in which it is administered suggesting that its metabolism is an 
important step in exerting its action (Chapter 2, section 2.3.3). Two forms of 
selenium commonly used in chemopreventive studies are sodium selenite and 
[Se]Met. Both compounds are converted by different pathways to F^Se which is a 
precursor molecule for the formation of [Se]Cys (Chapter 1, section 1.2). F^Se is 
also metabolised to form mono-, di- and tri-methylated selenium excretory 
products (figure 1.1). Compounds such as seleno-betaine (SB) and Se- 
methylselenocysteine (SMSC), which are converted to mono-methyl selenol, or 
dimethyl selenide (DMS), which is metabolised to dimethyl selenide, have also 
been demonstrated to have anti-carcinogenic activity (figure 1.5) (Ip and Ganther, 
1990; Ip et al., 1991). The relative efficiencies of these various compounds to 
inhibit carcinogenesis in the DMBA-induced mammary tumour system are as 
follows (Ip and Ganther, 1990; Ip et al., 1991):
SB = SMSC > Selenite > DMS 
Selenite>[Se]Met
It has been postulated that the anti-carcinogenic effects of selenium may be 
mechanistically related to its in vitro properties as an inhibitor of cell growth. It 
was therefore of interest to examine the growth inhibitory effects of these various 
selenium compounds in vitro and determine if there was any relationship between a 
compound's in vivo anti-carcinogenic and in vitro anti-proliferative properties. 
Seleno-compounds: SB, SBME, SMSC and DMS were a kind gift from Dr. 
Howard E. Ganther (Dept. Preventive Medicine, University of Texas, Galveston, 
Texas, USA). A mouse mammary cell line C57 (Vaidya et al., 1978), that had
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been derived from normal mammary tissue, was used for this study since the 
chemopreventive effect of selenium has been most extensively studied in mammary 
tumour models. The anti-proliferative potential was examined for sodium selenite, 
[Se]Met, DMS, SB and SMSC. After addition of selenium to logarithmically 
growing C57 cells, growth was monitored over a period of days by removing 
adherent cells with trypsin and measuring cell numbers using a Coulter counter. 50 
(iM sodium selenite had a marked inhibitory effect on cell growth after a lag phase 
of 48h (figure 4.1). Between 48h and 96h after selenite addition, cell number did 
not significantly increase whereas cells grown in the control medium continued to 
grow logarithmically. After 96h in selenite, cells began to die as indicated by a 
decrease in cell number (figure 4.1). The effect of selenite appeared quite specific, 
since [Se]Met, DMS, SB and SMSC at a concentration of 100|iM had little effect 
on the growth of C57 cells with only a 10-25% depression in cell number in 
comparison to the controls measured after 3d (table 4.1).
The initial delay of 48h before selenite began to inhibit cell growth suggested 
selenite may need to be metabolised to exert its action. Intracellularly, selenite is 
reduced to F^Se by GSH (Hsieh and Ganther, 1977). This is believed to be an 
important step in exerting its anti-proliferative effect since the addition of 
exogenous glutathione can potentiate the inhibitory effect of selenite on cell colony 
formation (Caffrey and Frenkel, 1990). The simultaneous addition of 50|iM GSH 
with 50(iM selenite was found to abolish the delay in growth inhibition observed 
with selenite alone, causing a decrease in cell number within 48h indicating cell 
death (figure 4.2). 50pM GSH alone had no effect on growth (figure 4.2).
4.2 Synthesis of SDG
The enhancing effect of GSH on the growth inhibitory effect of selenite 
suggested that selenite and GSH were reacting together to form a highly cytotoxic 
compound and that this was a rate limiting step in the effect of selenite. To test 
this hypothesis, the response of C57 cells to selenodiglutathione (SDG), the
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Figure 4.1
Growth of C57 cells as measured by cell number in control medium 
(•) or 50|aM sodium selenite (o). Points are mean ± S.D. of three 
measurements
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Cell num ber (xlO'4)
Days in culture
Compound 0 1 3 4
Control 8.9 24 ± 2 170 ±30 180 ± 10
[Se]Met 8.9 23 ± 3 150 ± 10 140 ± 10
SB 8.9 23 ± 3 150 ± 10 140 ± 10
SMSC 8.9 23 ± 3 150 ±20 130 ± 10
DMS 8.9 23 ± 1 130 ± 10 150 ± 10
Table 4.1
Cell growth of C57 cells, as measured by cell number, in control 
growth medium or lOOpM selenium. Values are mean ± S.D. of 
three measurements.
Abbreviations: [Se]Met - selenomethionine, SB - selenobetaine, 
SMSC - selenomethylselenocysteine and DMS - 
d imethylselen oxide.
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Figure 4.2
Growth of C57 cells as measured by cell number in control culture medium 
(•), 50(uM GSH (■), 50|aM sodium selenite (o) or 50[xM sodium selenite and 
50 (aM GSH (□). Points are mean + S.D. of three measurements.
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primary product from the reaction between selenite and GSH, was investigated 
SDG was synthesised essentially according to the method of Ganther (1971) (see 
chapter 3 section 3.2.10 for more details). In outline, SDG was synthesised in 
vitro by incubating selenite and GSH at a ratio of 1:4 at room temperature for 30 
min. A trace amount of 35S-GSH was also included in the reaction to enable the 
SDG to be monitored during subsequent purification steps. The reaction products, 
SDG and GSSG, were separated by ion exchange chromatography on Dowex-50 
resin columns saturated with nickel chloride. Nickel is incorporated into the 
column since it produces a differential retardation of SDG and GSSG such that the 
two products can be separated from the column as two distinct peaks with SDG 
eluting as the second peak (figure 4.3). Fractions from the second peak were 
pooled and adsorbed onto a second Dowex-50 resin column and washed with 
formic acid. This served to concentrate the SDG and remove the nickel. SDG was 
then eluted with ammonium acetate buffer. The buffer was exchanged for H2 O by 
chromatography of SDG-containing fractions on a GlOO-sephadex column and 
acetic acid was added to give a final concentration of lOmM. The purity of the 
SDG was confirmed using ultraviolet spectrum absorption analysis and thin layer 
chromatography (TLC). The ultraviolet absorption spectrum (figure 4.4) was 
identical to that reported previously for SDG (Ganther, 1971) with a peak at 
263nm and an absorbance extending to 400nm. TLC analysis of the SDG run in 
parallel against standards which contained GSSG, GSH or a mixture of selenite 
and GSH (figure 4.5) followed by ninhydrin staining, showed that SDG ran as a 
single spot and had the predicted mobility in relation to the other standards as 
reported by Ganther (1968).
4.3 Comparison of the effects of SDG and H202
A cloning assay was performed to determine the effect of SDG on cell 
viability. SDG was found to have a potent dose-dependent cytotoxic effect on C57 
cells with a significant reduction in cloning efficiency after a lh treatment in
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Figure 4.3
Separation of SDG and GSSG by chromatography on nickel chloride-saturated 
dowex-50 resin columns. 2ml fractions were collected and an aliquot measured for 
35S radioactivity. GSSG and SDG eluted as peaks land 2, respectively.
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Figure 4.4
Absorbance spectrum of SDG
figure 4.5
Figure 4.5
Thin layer chromatography followed by ninhydrin staining. Positions of GSH, 
GSSG and SDG were deduced from known standards (lanes 2-4) and are 
indicated by arrows. (1) purified SDG, (2) selenite and GSH mixed at a 4:1 
ratio and incubated for 0.5h at room temperature, (3) GSSG, (4) GSH
GSH
SDG
GSSG
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increasing concentrations of SDG (figure 4.6). It has been proposed that selenium 
may act by inducing a state of oxidative stress since addition of selenite to cells has 
been shown to generate superoxide anion and hydrogen peroxide (Yan and 
Spallholz, 1993) and selenite-induced DNA strand breaks are oxygen dependent 
(Garberg et al., 1988). It was therefore of interest to compare the cytotoxic effect 
of SDG and H2 O2  on C57 cells. H2 O2  was found to have a similar 
dose-dependent cytotoxic effect on C57 cells with a significant reduction in cloning 
efficiency after a lh treatment (figure 4.6).
4.3.1 SDG and H2 O2  induce similar morphological changes
Light microscopic analysis of cells treated with SDG or H2 O2  and stained 
with hematoxylin and eosin, revealed similar morphological changes. Both 8fiM 
SDG and 1.3mM H2 O2  induced the appearance of cytoplasmic convolutions within 
2h treatments (figures 4.7). However, no changes in gross nuclear and chromatin 
structure were evident at 2 or 4h (stained with the DNA-binding fluorochrome, 
DAPI) after treatment with either agent (figure 4.7). These morphological changes 
are suggestive of apoptosis but not in any way conclusive.
4.3.2 Induction of 50kb genomic DNA fragments is specific to SDG treatment
A common feature of apoptosis is the cleavage of genomic DNA into high 
molecular weight fragments (Oberhammer et al., 1993; Bicknell et al., 1994). 
Pulsed-field gel electrophoresis was used to analyse genomic DNA from C57 cells 
before and after SDG treatment since this technique enables separation and 
resolution of large DNA fragments ranging in size from 20kb to 2Mb. At time Oh, 
C57 genomic DNA consisted solely of high molecular weight material which did 
not migrate out of the well (figure 4.8A, lane 1). However, within lh  treatment 
with 8|iM SDG there was a clear induction of cleavage of genomic DNA into 
50Kb fragments (figure 4.8A, lanes 2-5) which could still be detected at 2,3 and 
4h. To a much lesser extent, SDG also caused cleavage of DNA into 560Kb
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Figure 4.6
Cloning efficiency of C57 cells after lh treatments with (A) SDG and (B) H^O^  
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figure 4.7
Figure 4.7
Hematoxylin- and eosin-stained cytospins of C57 cells before (A) and after 2h 
treatments with (B) 8pM SDG and (C) 1.3mM H2 O2 . DAPI-stained cytospins 
of C57 cells before (D) and after 4h treatments with (E) 8pM SDG and (F) 
1.3mM H20 2.
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figure 4.8
Figure 4.8
Pulsed field gel electrophoresis of DNA from C57 cells treated with (A) 8pM 
SDG for 0,1,2,3 and 4 h (lanes 1-5 respectively) and (B) 1.3mM H2 O2  for 
0,1,4,8 and 24h (lanes 4-8 respectively). In (B), as a control, C57 cells were 
treated with 8pM SDG for 2h (lane 3). Lanes 1 and 2 are molecular weight 
markers and X DNA (48Kb) respectively.
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fragments (figure 4.8A, lanes 2-5). The specific cleavage of genomic DNA into 
50Kb fragments is highly characteristic of apoptosis (Oberhammer et al., 1993). 
Cleavage of genomic DNA into 50Kb fragments, however, could not be detected 
in C57 cells treated with 1.3mM H2 O2  for 1,4,8 and 24h (figure 4.8B, lanes 4-8) 
although this concentration of H2 O2  is known to kill >95% of the cells (figure 4.6). 
There did however appear to be induction of cleavage of DNA into 560Kb 
fragments (figure 4.8B, lanes 4-8).
4.3.3 Differential effects of SDG and H2O2 on gene expression
To investigate further the cytotoxic effects of SDG and H2 O2 , the expression 
of a number of genes were studied in response to the two compounds. Northern 
analysis was used to determine the mRNA levels of PHGPX and GPX, 
seleno-enzymes responsible for H2 O2  detoxification, and the GST Ya subunit of 
GST a  which has selenium-independent glutathione peroxidase activity. A full- 
length cDNA probe for rat PHGPX was kindly provided by Dr. Roger Sunde 
(Nutrition Cluster, University of Missouri, Columbia, U.S.A.). For GPX, a cloned 
700bp EcoRl fragment from the mouse GPX gene containing exon 2 was used as 
a probe (Chambers et al., 1986). The probe for GST Ya detection was made as 
described in chapter 3, section 3.2.8.4. Briefly, reverse transcription was used to 
synthesise first strand cDNA from C57 total RNA using an oligo(dT) 
oligonucleotide as a primer. GST Ya cDNA was then amplified using primers 
designed from sequences that contain the translation initiation and termination 
codons, thus amplifying the entire coding region. The resulting 650bp fragment 
was sequenced using an automated sequencer and was found to agree with the 
published sequence of GST Ya (Daniel et al., 1987). Re-hybridisation of stripped 
filters with a cDNA probe for 7s rRNA was used as an internal loading control. 7s 
rRNA which is a component of the ribosome is relatively stable in comparison to 
mRNAs and was therefore a suitable choice as a measure of total RNA. The
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figure 4.9
Figure 4.9
Northern analysis to determine the levels of GPX, PHGPX and GST Ya mRNA 
levels after treatment with 1.3 mM H2 O2  for the indicated times. Figures below 
the autoradiographs indicate levels of mRNA relative to time zero using 7S 
rRNA as a loading control. Similar results have been obtained in two other 
experiments.
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Figure 4.10
Northern analysis to determine the mRNA levels of (A) PHGPX, (B) GPX, (C) 
GST Ya and (D) GAPDH after treatment with 8 pM SDG for the indicated 
times. Hatched bars indicate % levels of mRNA relative to time zero using 7 5  
rRNA as a loading control. Similar results have been obtained in 2-5 other 
experiments.
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relative amounts of test mRNA to 7s rRNA were calculated by densitometric 
analysis of autoradiographs.
Treatment of C57 cells with 1.3mM H2 O2  for lh  had no significant effect on 
the levels of any of the tested mRNAs (figure 4.9). In contrast, treatment with 8|i 
M SDG caused a down regulation of all three mRNAs by -50% within 40 min 
(figures 4.10). The northern blots were re-probed with a cDNA for the 
house-keeping gene GAPDH to determine if down-iegulation of GPX, PHGPX 
and GST Ya mRNAs was specific or just a consequence of a general lowering of 
mRNAs. GAPDH mRNA levels were found to be down-regulated in a similar 
manner with -50% reduction by 40 min (figure 4.10). This suggested that SDG 
was inducing a general down-regulation of mRNA levels. The different effects of 
SDG and H2 O2  on gene expression suggests that these two compounds act by 
distinct mechanisms.
4.4 Summary
The growth inhibitory potential on mammary C57 cells of a number of 
seleno-compounds that have varying degrees of anti-carcinogenic activities in 
animal tumour models were studied. Sodium selenite was found to be the most 
potent compound. However, the fact that (1) selenite only had an effect after a lag 
period of 48h, (2) GSH could abolish this delay in growth inhibition, and (3) SDG 
had a rapid cytotoxic effect and was more effective than selenite, suggested that 
selenite needed to be metabolised by reduction with GSH to exert a growth 
inhibitory effect.
The reduction of selenite by GSH has been shown to generate reactive 
oxygen species (Yan and Spallholz, 1993). Additionally, we and others have 
previously shown seleno-compounds, including SDG, to induce apoptosis (Lanfear 
et al., 1994; Lu et al., 1994; Thompson et al., 1994) and oxidative stress has been 
implicated in mediating apoptosis (Buttke and Sandstrom, 1994). The strong link 
between selenium metabolism, oxidative stress and apoptosis prompted us to test
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the hypothesis that SDG induces apoptosis in C57 cells and that this involves the 
generation of reactive oxygen species. SDG was found to induce the formation of 
560 and 50Kb DNA fragments which is suggestive of apoptosis (Oberhammer et 
al.y 1993; Bicknell et al., 1994). However, other key features of an apoptotic cell, 
notably chromatin condensation and nuclear fragmentation, could not be observed. 
SDG appeared to induce a cell death distinct from ^C^-induced oxidative stress 
as judged by (1) the maintenance of PHGPX, GPX and GST Ya mRNAs and (2) 
the absence of 50Kb DNA fragments during H202-induced cell death.
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Chapter 5
Generation of selenium-resistant mutants
5.1 Introduction
Since SDG appeared to be inducing cell death by a mechanism distinct from 
H2 O2 , a genetic approach was adopted to analyse the mechanism of SDG-induced 
cell death. A common strategy to studying mechanisms of drug action is the 
generation of drug-resistant cell lines derived from a drug-sensitive parental cell 
line. These lines can then be studied to determine biochemical differences that may 
be important for drug resistance with the possible identification of resistance genes. 
This approach minimises the problems of interpretation that occur when differences 
are being compared between cell lines derived from different sources, since 
changes are being identified against a common genetic background. Additionally, it 
is possible to identify genes that affect drug sensitivity that may not necessarily be 
affected by drug administration and so would not be detected when studying 
drug-induced effects.
A strategy was therefore devised to isolate selenium-resistant variants of C57 
cells. Traditionally, one approach to isolating drug-resistant cell lines is by 
growing cells in the presence of drug and increasing the concentration by small 
increments over a period of time. Partially resistant variants are therefore selected 
for with each successive increase in drug concentration. One disadvantage of this 
approach is that the resulting resistant cell line is likely to be heterogeneous and 
therefore consist of a mixture of different resistant variants. Furthermore, because 
the strategy involves multiple rounds of selection the mode of resistance may 
involve a number of mechanisms making interpretation of any differences between 
sensitive and resistant cell lines complex.
An alternative approach is a one-step selection whereby drug resistant cells 
are selected for in a high dose of drug. This strategy overcomes the problems 
associated with the multi-stage selection approach since the resistant variants are
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clonal and have arisen from one round of selection. A further advantage is that a 
number of independently arising resistant variants with different resistant 
mechanisms may be selected for in this manner. However, if the actions of a drug 
is bimodal with a high drug concentration having different effects from low drug 
concentrations, the resistance mechanisms that are selected for at a high drug 
concentration may not necessarily be the same as those that might be selected for 
in an incremental-dose selection strategy.
5.2 Choice of selective agent
A number of possible strategies for selecting selenium-resistant cells were 
evaluated. Initially, C57 cells were grown continuously in the presence of 50|iM 
sodium selenite. However, the delay of 24-48h before selenite had an effect 
proved problematical with this approach since after each refeeding, there would be 
no selective pressure for 24-48h during which non-resistant cells could recover and 
proliferate, thus reducing the enrichment procedure for potentially 
selenium-resistant cells. Additionally, other work in the group (Dr. A. Wong, 
unpublished data) demonstrated that the effect of selenite was cell 
density-dependent. A similar cell-density dependent effect of selenite-induced 
growth inhibition has also been demonstrated in other cell systems (Medina et al., 
1985; LeBoeuf et al., 1985). This explained the observed delay before selenite had 
an effect and suggested that selenite acted through the production of a secreted 
growth inhibitor that needed to reach a certain threshold concentration in the 
medium before having an effect. The fact that selenite toxicity was dependent on 
cell-density made selenite an unsuitable agent to select for selenium-resistant cells 
since it was impossible to ensure constant selective conditions. In view of the 
evidence that SDG is the active metabolite of selenite, SDG appeared to be a more 
suitable choice of agent for selection of selenium-resistant cells since it had a rapid 
cytotoxic effect and appeared to be cell density-independent. However, SDG is 
unstable in culture medium and loses all growth inhibitory activity within a 24h
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incubation period in 10% FCS at 37°C, compared to SDG added freshly to 
medium (figure 5.1). This obviously presented practical difficulties in maintaining 
a constant SDG concentration during selection. This would be critical for an 
incremental dose-selection strategy, since a drop in selective pressure would allow 
non-resistant cells to proliferate. This would be particularly problematical during 
the early rounds of selection when the kill-rate would be low. A one-step selection 
using a high SDG dose was therefore chosen to generate SDG-resistant variants of 
C57 cells.
5.3 Optimisation of conditions for selection
The frequency of a SDG-resistant cell spontaneously arising within a 
population of cells is dependent on a number of factors such as the mutation 
frequency, the spectrum of mutations or number of potentially mutable genes that 
may give rise to resistance, and whether the mutation is dominant or recessive. It 
was therefore necessary to determine the dose of SDG required to select for such a 
rare event. Conditions were therefore chosen to isolate a variant arising at a 
frequency of 1 SDG-resistant variant/105-106 viable cells.
A dose-response kill curve for C57 cells with SDG treatment was determined 
by measuring the cloning efficiency of C57 cells in the presence of increasing doses 
of SDG. This produced a more sensitive and accurate measurement of cell viability 
than other assays such as growth curves or 3H-thymidine uptake which are often 
used to assess cell survival. C57 cells were seeded into Petri dishes at a density of
1-4 x 105 cells/dish and allowed to adhere for 24h. The cells were then treated 
with a range of SDG concentrations and incubated for 10-14 days. In parallel, the 
plating efficiency of cells was determined by counting the number of colonies 
arising from 100 cells seeded into non-selective growth medium. The number of 
clonogenic cells seeded before SDG treatment could then be determined and the 
cloning efficiencies calculated and expressed as the number of colonies/viable cell. 
SDG produced a steep dose-response curve which was variable between
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Figure 5.1
Cloning efficiency of C57 cells in (A) fresh culture medium with 4.5pM SDG,
(B) culture medium with 4.5pM SDG after pre-incubation at 37°C for 24h and
(C) culture medium after pre-incubation at 37°C for 24h. Values are expressed 
as a percentage of the cloning efficiency of C57 cells in fresh culture medium. 
Bars are mean ± S.D. of four measurements.
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successive experiments (table 5.1). This fluctuation in kill-rate is probably due to 
factors in the culture medium that affect the intrinsic instability of SDG. These 
could include the ratio of GSHrGSSG which may fluctuate with culture medium 
age and therefore affect SDG degradation, or pH changes that occur when a large 
number of Petri dishes are being manipulated in the low CO2  atmosphere of a 
tissue culture hood. A number of steps were therefore taken in order to try and 
standardise the SDG dose-response curve. Foetal calf serum was aliquoted, stored 
at -20°C and thawed only as required to minimise the time it was kept at 4°C. 
HEPES buffer was also added atlOmMto minimise pH fluctuations in the culture 
medium. However, despite these precautions, consistent dose-response curves 
were unobtainable. In each experiment, a range of SDG concentrations was 
therefore chosen to select for resistant mutants. This ensured that for any given 
experiment a dose of SDG that gave the desired kill would be included.
5.4 Selection of SDG-resistant mutants
From experiment 1 (table 5.1) 3 colonies (C57A, B and G) that had arisen in 7 
jiM SDG at a frequency of 1.3/105 viable cells were isolated. These were tested 
for an increased resistance to SDG as compared with the parental C57 cells by 
measuring cell growth over a period of 3 days in the presence and absence of 7fiM 
SDG. For convenience, growth was monitored by measuring nucleic acid 
concentration of cell lysates, as determined by measuring absorbance at 260nm. 
This figure was assumed to be linearly related to cell number. In the absence of 
SDG all three clones grew at a similar rate to that of C57 cells. However, in the 
presence of 7pM SDG, one clone, C57A, had a significantly higher number of cells 
1 and 3 days after SDG addition as compared with C57 cells and the other 2 clones 
(figure 5.2). Additionally, under cloning conditions, C57A cells were also more 
resistant (figure 5.3). However, this difference was marginal and was only stable 
for about 40 days growth in non-selective media after which C57 and C57A cells 
displayed similar SDG sensitivities (figure 5.3). This suggested that C57A cells
85
Expt.l: 
Expt 2:
Cloning Efficiency (xlO'5) (colonies/viable cell)
[SDG] pM
2 4 5 6 7 10
Confluent Confluent 1.3 <0.1
500 46 7.8 0.25
Table 5.1
Cloning efficiency of C57 cells in the presence of SDG. Values were calculated 
as a mean of 5-10 plates.
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Figure 5.2
Cell growth, as measured by absorbance of cell lysates at 260nm, of C57 
(circles), C57A (diamonds), C57B (triangles) and C57G (squares) cells in 
control culture medium (solid shapes) and 7pM SDG (open shapes). Points 
are mean 4= S.D. of three measurements.
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Figure 5.3
Cloning efficiency of C57 (•) and C57A (o) cells in SDG after (A) 20 and 
(B) 40 days culture in the absence of SDG. Points are mean ± S.D. of three 
measurements.
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had acquired some unstable epigenetic change that conferred a SDG-resistant 
phenotype only transiendy. C57A cells were therefore an unsuitable system in 
which to study mechanisms of SDG resistance.
5.5 Mutagenesis of C57 cells prior to selection in SDG
In the generation of drug resistant lines, cells are commonly treated with 
mutagen prior to selection to increase the mutation frequency. A commonly used 
mutagen is ethyl methanesulphonate (EMS) which is a monofunctional ethylating 
agent EMS has been shown to cause a wide range of mutations covering base pair 
transitions, insertions and deletions to more extensive intragenic deletions and 
chromosome breaks (Sega, 1984). Since it is unknown what type of mutations are 
likely to give rise to SDG resistant mutants, EMS seemed a suitable choice of 
mutagen for use in the single step selection approach.
5.5.1 Optimisation of conditions for mutagenesis
The dose of EMS with which to mutagenize C57 cells prior to selection was 
decided by constructing a dose-response kill-curve. The cloning efficiency of 
logarithmically growing C57 cells was determined after treatment with increasing 
concentrations of EMS for 2h in serum-free growth medium (figure 5.4). A 
concentration of 1.75mg/ml EMS was chosen as this gave a survival rate of 20%, a 
figure which is commonly used by other workers.
5.5.2 Selection of SDG-resistant mutants after mutagenesis with EMS
After mutagenesis with EMS, C57 cells were incubated for 24h in the absence 
of mutagen. Cells were then seeded into Petri dishes at a density of 2 x 105 
cells/dish and incubated for a further 24h. A total of 48h incubation in 
non-selective growth medium post EMS treatment allowed the cells to both 
recover from the mutagenic insult and express any mutations, such as transcription 
of genes that have been activated or degradation of mRNA from genes that have
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Figure  5.4
Cloning efficiency of C57 cells after a 2h exposure to EMS in serum-free 
culture medium. Points are mean ± S.D. of three measurements.
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been silenced Mutagenized cells were then exposed to either 5 or 6pM SDG and 
incubated for 10-14 days. From cells treated with 6[iM SDG, five colonies were 
isolated from a total of 1.8 x 106 viable cells plated. All five clones displayed 
varying degrees of resistance to SDG when re-cloned in SDG (table 5.2). 
However, only 2 clones (B15 and B19) remained stably resistant after at least 50 
days growth in non-selective growth medium suggesting that the resistant 
phenotype was due to some stable genetic change (figure 5.5). Differences in 
cloning efficiencies in SDG of C57 cells compared to B15 or B19 cells were 
statistically significant over a range of SDG-concentrations (figure 5.5).
5.6 Comparison of selenium-resistant and -sensitive cell lines
Drug resistance may be acquired by a variety of mechanisms such as 
decreased drug uptake or metabolic activation, or increased detoxification. 
Additionally, pathways through which the drug induces cell death may be altered 
and this could affect drug sensitivity indirectly. A number of approaches were 
therefore adopted to identify biochemical changes conferring resistance to SDG. 
B19 cells were chosen for this purpose as they displayed the greatest resistance to 
SDG.
5.6.1 B19 cells are cross-resistant to sodium selenite but not H202
Sensitivity to growth inhibition by selenite was measured for C57 and B19 
cells to determine if the mutation(s) acquired by B19 cells specifically conferred 
resistance to SDG or affected sensitivity to other selenium compounds. 
Logarithmically growing C57 and B19 cells were exposed to 50pM sodium 
selenite and cell growth monitored over a period of days by measuring cell number. 
Both cell lines displayed the same delay of 24h before selenite began to inhibit cell 
growth. However, B19 cells were inhibited to a significantly lesser extent 
thereafter (figure 5.6A). B19 cells were therefore resistant to the growth inhibitory 
effects of both SDG and selenite.
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Cloning Efficiency
[SDG] jaM
Cell Line 0 3.5 4.5
B15 100 49 1
B16 100 47 4
B17 100 105 2
B18 100 67 0
B19 100 100 20
C57 100 21 0
Table 5.2
Cloning efficiency of C57 cells and four clones selected in 6juM 
SDG. Values are mean ± S.D. of three measurements.
figure 5.5
Figure 5.5
Cloning efficiency of C57 cells (closed circles) in SDG compared to (A) B15 
and (B) B19 cells. Poins are mean ± S.D. of three measurements, {a, p<0.1; b , 
p<0.05; c, p<0.001, students /-test.)
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Figure 5.6
Comparison of the sensitivity of C57 and B19 cells to (A) 50pM selenite as 
judged by cell number and (B) H2Q  as judged by cloning efficiency. Points 
are mean ± S.D. of three measurements.
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Since SDG had different biochemical effects in C57 cells from H2 O2 , such as 
production of 50Kb fragments and down-regulation of PHGPX, GPX and GST Ya 
mRNA levels, it was also of interest to determine if sensitivity to H2 O2  was altered 
in B19 cells. However, cloning efficiencies after a lh  treatment with increasing 
concentrations of H2 O2  were not significandy different between the two cell lines 
(figure 5.6B).
5.6.2 Rates of selenium-uptake are similar between B19 and C57 cells
Selenite uptake was measured between the two cell lines to determine if 
different rates of selenium uptake could be responsible for SDG-resistance. 
~70nM [75Se]-sodium selenite was added to logarithmically growing C57 and 
B19 cells and incubated at 37°C. At various time points, the culture medium was 
removed and cells were rinsed with phosphate-buffered saline. Adherent cells were 
then lysed in situ with 0.1M NaOH and the 75Se radioactivity in the cell lysates 
was measured in a y-radiation counter. The selenium uptake of cell lysates was 
measured over a period of 48h. During this period no significant difference in 
selenite uptake could be observed between the two cell lines (figure 5.7).
5.6.3 Intracellular GSH concentration is similar in C57 and B19 cells
The initial fate of selenite upon entry into a cell is reduction to selenide by 
GSH. This reduction appeared to be a rate-limiting step in the anti-proliferative 
effect of selenite since GSH potentiated the effect of selenite and SDG was a much 
more potent growth-inhibitor than selenite (compare figures 4.2 and 4.6). 
However, it is unknown if SDG has a direct effect or it too requires further 
reduction by GSH. It was therefore possible that B19 cells had a lower GSH 
concentration and that this affected the metabolism of selenite and SDG. The GSH 
levels in lysates from logarithmically growing C57 and B19 cells were therefore 
measured using an enzymatically recycling reaction in which glutathione is 
sequentially oxidized by 5,5’-dithio-bis-(2-nitrobenzoic acid) and reduced by
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Figure 5.7
Selenite uptake in C57 (o) and B19 (•) cells as measured by cpm of lysates from 
cells grown in [7SSe]-sodium selenite. Figures are mean ± S.D. of three 
measurements.
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NADPH and glutathione reductase. The production of the chromophoric product,
2-nitro-5-thiobenzoic acid, is thus directly proportional to the glutathione
concentration and can be detected by absorbance at 412nm (see chapter 3, section 
3.2.12 for details). Intracellular GSH concentrations were found to fluctuate 
between experiments for reasons that remain unclear. However, within
experiments, where cells were exposed to identical growth conditions, no 
statistically significant difference (students f-test) in intracellular GSH 
concentrations between C57 and B19 cells could be detected (table 5.3).
5.6.4 Differences in gene expression between C57 and B19 cells
To further investigate the mechanism of selenium-resistance, the mRNA levels 
of a number of genes were compared between C57 and B19 cells. Although SDG 
did not appear to mediate all its effects through the generation of H2 O2 , the role of 
other ROS and organic peroxides, which are substrates for these enzymes, could 
not be eliminated. The mRNA levels of PHGPX, GPX and glutathione
S-transferase a  (GST a), which displays a selenium-independent glutathione
peroxidase activity towards organic peroxides, were therefore investigated. 
Another GST family member, GST n, was also of interest since it is commonly 
involved in resistance against a wide spectrum of drugs. The mRNA levels of 
thioredoxin (TRX) was also investigated since both selenite and SDG in cell-free 
systems are potent inhibitors of this redox factor (Bjomstedt et al., 1992; Kumar et 
al., 1992). The probes used to determine PHGPX, GPX and GST Ya mRNA 
levels were those previously described in chapter 4, section 4.3.3. The probe for 
TRX was made as described in chapter 3, section 3.2.8.4. Briefly, reverse 
transcription was used to synthesise first strand cDNA from C57 total RNA using 
an oligo(dT) oligonucleotide as a primer. TRX cDNA was then amplified using 
primers designed from sequences that contain the translation initiation and 
termination codons, thus amplifying the entire coding region. The sequence of the 
resulting 340bp fragment was confirmed by automated sequencing. Full length
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Cell line [GSH] mg GSH/ g protein
E x p t1: C57 2.2 ± 0.4
B19 3.0 ± 0.5
Expt 2: C57 1.0 ±0.4
B19 1.5 ±0.3
Expt. 3: C57 4.3 ±1.0
B19 4.6 ±1.0
Table 5.3
Comparison of glutathione concentrations between C57 and B19 
cells. Values are mean ± S.D. of four measurements for expt.l and 
three measurements for expts. 2 and 3.
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cDNA probes for GST n and GST Yc were kindly provided by Professor Roland 
Wolfe and Dr. John Hayes (both of ICRF, Biomedical Research Centre, Dundee, 
U.K.), respectively. Quantitation of mRNA levels was performed as described in 
chapter 4, section 4.3.3 using 7S rRNA as an internal loading control. mRNA 
levels were analysed in untreated C57 and B19 cells since it was possible that the 
mechanism of selenium resistance is constitutively active. Analyses were carried 
out on at least four independent RNA preparations for each cell line and the 
students f-test was used to determine any statistical significance for any differences 
detected between the two cell lines.
No significant differences were apparent for GPX, TRX, GST Yc and GST n 
mRNA levels between the two cell lines (figure 5.8). However, a significant 
(p<0.01) 2-fold down-regulation of PHGPX mRNA in B19 cells was observed. In 
contrast, GST Ya mRNA levels were significantly (p<0.1) 2-fold higher in the B19 
cells. Although the GST Yc mRNA levels in the two cell lines were not 
significantly different at the p<0.1 level, the mean level (4 experiments) of GST Yc 
mRNA in B19 cells was 1.8-fold higher than the level observed in C57. Of the 
various GSTs, GST k mRNA levels appeared to be considerably higher than GST 
Ya and GST Yc mRNA levels as judged by the period of autoradiography required 
for a signal to be detected for the various mRNA species (<24h for GST n versus
3-7d for GST Ya and GST Yc).
Since SDG appeared to induce a cell death reminiscent of apoptosis, as judged 
by the appearance of 50Kb DNA fragments, the mRNA levels of a number of 
apoptosis-regulating genes were also analysed, namely bcl-2 and bcl-x. BCL-2 is a 
membrane associated protein which can inhibit apoptosis induced under a number 
of conditions. The bcl-x gene encodes two gene products that are homologous to 
BCL-2 and result from differential splicing of the bcl-x transcript to give bcl-x$ and 
bcl-Xi mRNAs. bcl-xL encodes a protein that has similar apoptosis-inhibiting 
functions as BCL-2 whereas BCL-Xs can antagonise BCL-2 function. A mouse 
bcl-2 cDNA was kindly provided by Dr. Christopher Bartholomew (Beatson
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Institute for Cancer Research, Glasgow, U.K.). PCR was used to amplify the first 
430bp of the bcl-x coding region from human genomic DNA (kindly provided by 
Kevin Ryan, Beatson Institute for Cancer Research, Glasgow, U.K.) since its 
sequence is common to both splice products. The sequence was confirmed by 
automated sequencing, bcl-2 and bcl-x^ mRNA levels were not significantly 
different between the two cell lines (figure 5.9). However, there was a significant 
(p<0.05) 2-fold reduction in bcl-x$ mRNA in B19 cells (figure 5.9).
5.6.5 Differences in selenoprotein levels between C57 and B19 cells
Since selenite uptake and GSH concentration levels were similar between the 
two cell lines, the mechanism of selenium resistance may involve steps further 
downstream of selenium metabolism. Selenium functions primarily through the 
production of selenoproteins, such as GPXs, which contain [Se]Cys encoded by an 
in-frame UGA codon. Additionally, selenium-binding proteins exist that bind 
selenium in an unidentified manner. One hypothesis, therefore, as to how selenium 
acts as an anti-proliferative agent is through the production of a growth inhibitory 
selenoprotein(s) or selenium-binding protein(s). To investigate this hypothesis, the 
selenoprotein and selenium-binding protein complement of C57 and B19 cells was 
analysed. 18.5 |iCi [75Se]-selenite was added to logarithmically growing cells and 
incubated for 96h. Culture medium was then removed, cells were rinsed with 
phosphate-buffered saline and adherent cells were lysed in situ. In collaboration 
with Lynn McGarry, two samples each from duplicate flasks of each cell line were 
analysed by 2D gel electrophoresis and autoradiographs of each gel were 
quantitated by densitometric analysis. Visual inspection of the autoradiographs 
(four per cell line) revealed that the complement of selenium-labelled proteins from 
the two cell lines are very similar with a total of 26 spots detected that ranged in 
size from 19 - lOlKDa (table 5.4). A more detailed analysis was performed using 
densitometric quantitation between the two cell lines. For each cell line, gels were 
normalised to each other by expressing the intensity of each spot relative to that of
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figure 5.9
Figure 5.9
Northern analysis to determine the relative mRNA levels of a number of genes in 
C57 and B19 cells. Points are from independent experiments and indicate 
B19:C57 ratio of band intensities relative to 7Si‘RNA. Arrows indicate mean ratio 
for each mRNA examined (a, p<0.05, students Mest)
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Spot Number Apparent MW (kDa) Approximate pi
1 77.2 7.42
2 18.5 5.38
3 (t) 29.0 5.10
4 49.1 5.02
5 66.2 6.02
6 (T) 19.0 6.88
7 (t) 35.0 5.08
8 47.0 6.85
9 54.5 5.04
10 42.3 5.03
11 21.1 5.27
12 22.5 6.13
13 (*) 72.2 6.33
14 (*) 72.5 6.45
15 82.8 6.49
16 23.4 5.27
17 (t) 71.3 6.64
18 (I) 101.3 5.63
19 66.0 6.38
20 25.9 5.27
21 (I) 99.8 5.40
22 83.0 6.70
23 19.0 4.94
24 22.5 7.17
25 22.5 6.87
26 82.8 6.84
Table 5.4
Estimated molecular weights and isoelectric points of selenium-labelled proteins 
identified by 2D gel analysis, (symbols in parentheses: T. spot-intensity increased 
in B19 cells; I, spot-intensity decreased in B19 cells; *, spot absent from C57 cells; 
see section 5.6.5 and figure 5.10 for details)
103
spot 19 which was taken as 1 (figure 5.10D). Spot 19 was chosen as the reference 
spot since it appeared as a discrete spot in all 8 gels and did not appear to be 
maikedly different between the two cell lines by visual inspection. The intensity of 
each spot in relation to spot 19 was then calculated for all four gels. The set of 
values obtained for each spot for each cell line was compared between the two cell 
lines and the students f-test used to determine any statistically significant 
differences.
Both qualitative and quantitative differences were observed between the two 
cell lines. Two proteins having a molecular weight of 72Kda (spots 13 and 14) 
which were present in B19 cells could not be detected in C57 cells (figure 5.10B). 
Additionally, spots 3, 6, 7 and 17 (molecular weights 29, 19, 35 and 73KDa, 
respectively) were significantly more intense in B19 cells than the corresponding 
spots in C57 cells by 2-5 fold (p<0.05 for spots 3,6 and 7; p<0.002 for spot 17) 
(figure 5.10D). In contrast, spots 18 and 21 (molecular weights 101 and lOOKDa, 
respectively) were significantly more intense in C57 cells than in B19 cells by 
approximately 2-fold (p<0.01, p<0.02 for spots 18 and 21, respectively) (figure 
5.10D).
A number of spots, notably 11, 16, 20, 24 and 25 with molecular weights 21, 
24, 27 23 and 23 KDa, ran as smears (figure 5.10A). Spots 24 and 25 most likely 
contained the subunits of PHGPX and GPX which could be detected at relatively 
high levels by northern analysis (figure 4.9). Interestingly, the intensity of these 
two spots were not significantly different between the two cell lines suggesting that 
the difference detected in the levels of PHGPX mRNA between the two cell lines 
may not be biologically significant However, spots 24 and 25 did not fully resolve 
and ran as a smear and it is therefore debatable if a 2-fold difference could be 
detected for either of these spots.
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Figure 5.10
2D gel analysis of selenium-labelled proteins.
(A) Autoradiographs of 2D protein gels from C57 and B19 cells labelled with [75Se]- 
selenite. A representative gel, from a total of four, for each cell line is shown.
(B) Expanded area of gels from (A) showing the absence of two 72KDa spots from C57 
cells and their presence in B19 cells. Spot 19 is indicated to aid orientation.
(C) Composite diagram of gel spots from both cell lines. Spots are numbered in order of 
increasing intensity. Open circles indicate those spots only found in B19 cells. Dashed 
lines encompass protein spots that ran as smears.
(D) Spot intensities relative to spot 19 for each of four gels for C57 (open squares) and 
B19 (filled squares) cells. Arrows indicate spots, the intensities of which are statistically 
significantly different between the two cell lines, {a, p<0.05; b, p<0.02; c, p<0.01; d, 
p<0.002, students f-test; *, not present in C57 cells).
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5.7 Summary
A genetic approach has been taken to investigate the mechanisms of 
selenium-induced growth inhibition by generating selenium-resistant variants. A 
number of strategies were evaluated with which to select potential resistant-cells 
and a one-step clonal selection using a high dose of SDG seemed the most suitable. 
Initially, conditions were devised to isolate clones arising at a frequency of 1 
clone/105-106 viable cells. However, using this kill-rate was unsuccessful and it 
only gave rise to one variant that was only transiently resistant. Increasing the 
mutation frequency by treatment with EMS prior to selection in SDG gave rise to 
two SDG-resistant clones that were stable for at least 50 doubling times. The 
resistant variant, B19, was chosen for further analysis since it displayed the 
greatest degree of resistance.
B19 cells were also resistant to selenite cytotoxicity. However, the lag period 
before selenite had an effect was the same for both cell lines. The fact that B19 
cells are cross-resistant to selenite supports (1) the conclusion that B19 is 
selenium-resistant and (2) the hypothesis that selenite is acting through the 
production of SDG. Differential selenium uptake and GSH concentrations, which 
might affect selenite/SDG metabolism, were eliminated as possible mechanisms of 
resistance since these parameters were unchanged in the B19 cells. However, 
other comparative studies revealed a number of differences between C57 and B19 
cells.
The mRNA levels of a number of candidate genes that could be involved in 
selenium-resistance was investigated. GST a  subunits mRNA levels were 
approximately 2-fold higher in B19 cells. In contrast, PHGPX and Bcl-xS mRNA 
levels were found to be approximately 2-fold lower in B19 cells.
The selenium-labelling protein complements of C57 and B19 cells were also 
compared to identify selenoproteins or selenium-binding proteins that may be 
functionally involved in the resistant phenotype. A number of proteins were 
identified, the labelling of which were altered in the B 19 cells. The most striking
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difference was the presence of two 72KDa proteins which were not apparent in 
C57 cells.
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Chapter 6 
Discussion
6.1 Cytotoxic effects of selenite requires metabolic activation
In this study, the molecular mechanisms of selenium-induced growth 
inhibition have been investigated using a mouse mammary cell line, C57. Of a 
number of seleno-compounds, sodium selenite appeared to be the only compound 
that significandy affected the growth of C57 cells at the concentrations tested. 
Selenite had a cytotoxic effect after a lag period that could be abolished by the 
simultaneous addition of GSH. Other work in the group suggested that selenite 
toxicity was cell density-dependent (Dr. A. Wong, unpublished data), which has 
also been shown for other cell lines (Medina et al., 1985; LeBoeuf et al., 1985) 
and that selenite was acting through a secreted growth inhibitor (Dr. A. Wong, 
unpublished data). Additionally, SDG, the primary metabolite from the reaction of 
selenite and GSH was found to be a far more potent cytotoxic agent than selenite 
and had a cell density-independent effect as judged by its ability to act on C57 cells 
under cloning conditions. Other workers have also demonstrated SDG to be a 
potent cytotoxic agent (Santoro and Milner, 1991) and more effective than 
selenite in vitro (Fico et al., 1986). The simplest interpretation of these results is 
that selenite needs to be metabolised by way of its reduction by GSH to have a 
toxic effect. This is in agreement with a number of studies that have also shown 
that the simultaneous addition of GSH can enhance the toxic effects of selenite on 
human and canine mammary tumour cells and HL60 cells (Yan et al., 1991; 
Kuchan and Milner, 1991; Batist et al., 1986). One question arising from the 
enhancing effect of exogenous GSH on selenite toxicity is why concentrations of 
50-250 fiM GSH (50 |iM GSH in this study) increase the severity of the effect of 
selenite so dramatically since selenite can permeate C57 cells within 2h upon 
addition to the culture medium and intracellular concentrations of GSH are 
generally in the millimolar range (Meister, 1988). Furthermore, hepatocytes begin
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to produce dimethyl selenide within 4h of selenite addition (Annundi et al., 1984). 
Selenite is therefore rapidly taken up by cells and enters intermediary metabolism 
almost immediately. It is therefore puzzling as to why the high intracellular 
concentration of GSH does not have the same enhancing effect on selenite as 
relatively low extracellular concentrations of GSH.
Studies to determine the effect of intracellular GSH on selenite toxicity 
have been inconsistent. Buthionine sulphoximine (BSO), an agent that inhibits 
y-glutamylcysteine synthetase, an enzyme involved in GSH synthesis, has been 
shown to enhance and inhibit selenite toxicity in human mammary cells (Yan et al., 
1991) and HeLa cells (Caffrey and Frenkel, 1991), respectively. Additionally, 
selenite and SDG treatment can affect intracellular levels of GSH; however, 
increases, decreases and no effect at all on GSH levels have been observed 
depending on cell type (Santoro and Milner, 1991; Yan et al., 1991; Kuchan and 
Milner, 1991). These conflicting findings may be explained by the fact that while 
selenite reduction is required for its activation to more toxic compounds such as 
SDG, intracellularly, selenite reduction is also involved in cellular selenite 
detoxification since selenite needs to be reduced to selenide before it can be 
methylated and excreted (figure 1.1). The intracellular ratio of GSHiselenite could 
therefore critically affect selenite toxicity. Any changes in this ratio would not only 
affect the relative levels of potentially toxic seleno-metabolites, such as SDG, but 
also the rate of their detoxification. Ganther (1971) showed that under cell-free 
conditions, SDG is most favourably produced when the GSHiselenite ratio is 4 or 
less and that when the ratio exceeds 4, glutathione selenopersulphide becomes the 
dominant species. Additionally, Kuchan and Milner (1992) find that the molar 
ratio of GSHiselenite negatively correlates with the extent of growth inhibition by 
selenite. The GSHiselenite ratio may also be affected by cell density which has 
been shown to lower GSH concentration (Kuchan and Milner, 1992) and increase 
selenite toxicity (Medina et al., 1985; Kuchan and Milner, 1992). The 
consequence of altering the intracellular GSH levels will not solely depend on the
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GSH:selenite ratio but will also be influenced by a number of factors such as other 
cellular sulphydryls which may compete with GSH to react with selenite to form 
other selenotrisulphides. Under conditions where GSH levels have been depleted, 
selenotrisulphides such as selenodicystine [(NH2 (COOH)CHCH2 S)2 Se] or 
selenodimercaptoethylamine [(NH2 CH2 CH2 S)2 Se] are produced, which may have 
similar or even different toxic effects to SDG (Frenkel et al., 1991). For example, 
Frenkel and Falvey (1988) showed that diethylmaleate, which produces a 
non-specific depletion of thiols, could decrease the the degree of DNA synthesis 
inhibition induced by selenite whereas BSO, which specifically depletes GSH, did 
not. It was therefore suggested that a selenotrisulphide, but not SDG, was 
responsible for selenite inhibition of DNA synthesis. The formation of SDG or 
other selenotrisulphides may thus be a mechanism by which selenite is metabolised 
to a more toxic agent but this may not occur in some cell systems due to 
intracellular physiological conditions favouring detoxification. The lag period of 
selenite's effect on C57 cells may thus represent a period when GSH levels are 
being altered either as a process of selenite metabolism or increased cell density. 
During this period the GSHiselenite ratio may favour selenite detoxification. 
However, the GSHiselenite ratio may reach a certain threshold where toxic 
seleno-compounds may begin to accumulate and at this point selenite begins to 
have its cytotoxic effect
Whether selenite actually kills C57 cells by the accumulation of SDG or 
whether other selenotrisulphides are involved is unknown. Additionally, assuming 
SDG is the active metabolite of selenite, it is unknown if adding SDG exogenously 
kills cells by the same mechanism as selenite since presumably selenite generates 
SDG intracellularly, yet it is unknown if exogenous SDG enters cells or acts 
extracellularly. However, the fact that B19 cells are resistant to both SDG and 
selenite strongly suggests that SDG is exerting some if not all of the effects of 
selenite and that their site of action, that is whether they act intra- or
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extracellularly, results in the activation of similar if not identical pathways leading 
to cell death.
6.2 Selenite and SDG induce cell death by a mechanism distinct from H2 O2  
toxicity
Selenite reduction by GSH has been shown to generate superoxide and 
H2 O2  (Yan and Spallholz, 1993) and Seko et al. (1989) has proposed a reaction 
sequence for the reduction of selenite by GSH resulting in the production of 
superoxide anion, which is converted to H2 O2  by superoxide dismutases (figure 
6.1 A). Additionally, selenite-induced DNA strand breaks have been shown to be 
oxygen-dependent (Garberg et al., 1988). Oxidative stress is therefore strongly 
implicated in the toxic effects of selenite (Spallholz, 1994). In this study, this 
hypothesis has been tested by comparing the various biochemical effects of SDG 
and H2 O2 .
Both agents had a rapid effect and markedly reduced cloning efficiency 
within lh. Interestingly, H2 O2  was found to be required at concentrations 
reaching 200 fold higher than SDG to have a similar cytotoxic effect. This is 
contrary to what would be expected from the reaction proposed by Seko et al. 
(1989) which indicates that one molecule of SDG should give rise to one molecule 
of superoxide anion which would give rise to one molecule of H2 O2  (figure 6.1 A). 
This might suggest that SDG is acting through a very specific mechanism rather 
than just generating reactive oxygen species as by-products of its metabolism. This 
stoichiometric anomaly has been addressed in a hepatocyte system by Hogberg and 
his colleagues: the metabolic conversion of selenite to dimethyl selenide occured 
after a lag period during which selenium accumulated in the cell and changes in the 
GSH redox system took place, as judged by oxygen consumption, oxidation of 
GSH and depletion of NADPH (Annundi et al., 1984). Together with the 
suggestion that SDG and Se^' may autooxidize (Tsen and Tappel, 1958; Ganther, 
1979; Dilworth and Bandurski, 1977) they postulated a reaction scheme whereby
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Figure 6.1
(A) Reaction scheme showing the metabolic reduction of selenite with the 
concomittant conversion of reduced glutathione (GSH) to oxidised 
glutathione (GSSG) and generation of superoxide. Adapted from Seko et al. 
(1989).
(B) Reaction scheme showing selenite and selenite-metabolites entering into 
redox cycles and the concommitant consumption of oxygen. Adapted from 
Annundi etal. (1984)
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selenite metabolites induce a state of hypoxia (Garberg and Hogberg, 1987) by 
entering redox cycles from which reactive oxygen species (ROS) may be generated 
(figure 6. IB). Therefore it is possible that the metabolism of low concentrations of 
selenite/SDG could result in the formation of toxic quantities of ROS, such as 
H2 O2  which can mediate some of the effects of SDG in C57 cells such as 
formation of 560Kb DNA fragments and induction of similar morphological 
changes. However, other data strongly suggests that selenite/SDG cytotoxicity 
requires signals other than the production of H2 O2 . The observation that B19 
cells are resistant to both SDG and selenite but not H2 O2  demonstrate that these 
two pathways resulting in cell death can be segregated genetically and that SDG 
has additional effects besides generating H2 O2 . However, since H2 O2  is thought 
to arise from the reductive metabolism of selenium, an alternative interpretation 
could be that the B19 cells have acquired some mutation that inhibits events 
upstream of selenite/SDG induced production of H2 O2  such as selenium uptake or 
metabolism. In such a situation, H2 O2  could mediate the effects of SDG but B19 
cells would still be SDG-resistant due to the fact that less H2 O2  were produced. 
However, this seems excluded since the rate of selenite uptake and the glutathione 
concentration of the two cell lines are not significantly different Furthermore, 
although B19 cells are resistant to the eventual toxic effects of selenite, the lag 
period of selenite toxicity is similar between C57 and B19 cells suggesting that the 
reductive pathway of selenite metabolism is intact in the B19 cells and that the 
mutation(s) conferring selenium resistance affects steps after selenite conversion to 
more toxic seleno-metabolites. The absence of 50Kb DNA fragments and 
maintenance of PHGPX, GPX and GST Ya mRNA levels during H202-induced 
cell death further indicates that there are fundamental mechanistic differences 
between the cytotoxic effects of SDG and H2 O2 .
The fact that H2 O2  toxicity cannot account for the effects mediated by 
SDG does not exclude the involvement of oxidative stress in SDG toxicity. For 
example, superoxide which is also generated from GSH reduction of selenite (Yan
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and Spallholz, 1993) may have additional or different effects to H2 O2 . Although 
superoxide presumably is converted to H2 O2  this will be dependent on the levels 
and activity of superoxide dismutases. Regarding the role of other ROS, the 
SDG-mediated down-regulation of PHGPX, GPX and GST Ya mRNAs in relation 
to 7 s rRNA may be of functional significance. Since cells are continuously 
generating ROS as by-products of general oxidative metabolism, any lowering of 
the oxidant defences of the cell would augment the intracellular levels of not only 
H2 O2  but also other ROS and organic peroxides which may elicit different or 
additional effects from H2 O2  alone. Such a mechanism has been proposed for the 
growth inhibition of rat hepatocytes by TGF-pi, which down-regulated the mRNA 
levels of Mn and Cu-Zn superoxide dismutases, catalase and GST subunits 1 and 2 
and caused a concomitant increase in the level of intracellular peroxides (Kayanoki 
et al., 1994). SDG may therefore be inducing a pro-oxidant state by a similar 
mechanism. However, the lowering of GAPDH mRNA levels suggests that 
SDG-induced down-regulation of PHGPX, GPX and GST Ya is non-specific and 
that SDG is most likely causing a general inhibition of RNA synthesis, as has been 
reported for selenite. The fact that the levels of 7S rRNA are unaffected after SDG 
treatment probably reflects the higher stability of rRNAs over mRNAs. The 
functional significance of inhibition of RNA synthesis by SDG is unclear. For 
example, it is unknown if RNA inhibition is a direct effect of SDG or is affected 
indirectly as a consequence of, say, protein or DNA synthesis inhibition which has 
been reported for selenite in other systems (Vemie et al., 1983; Frenkel and 
Falvey, 1988)). However, Fico et al. (1986) has demonstrated that the inhibition 
of RNA synthesis, but not DNA or protein synthesis correlates with 
selenium-induced growth suppression. Whatever role down-regulation of PHGPX, 
GPX and GST Ya plays during SDG-induced cell death, it appears to be an early 
event since it precedes detachment of cells from the monolayer.
Inhibition of cellular oxidant defences could alternatively be achieved 
post-transcriptionally by inhibiting the activity of antioxidant enzymes. Indeed,
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selenite and SDG may induce a pro-oxidant state by such a mechanism as they are 
both powerful inhibitors in cell-free systems of the redox factor, thioredoxin 
(Bjomstedt et al., 1992; Kumar et al., 1992), which is involved in free radical 
defence (Nonogaki et al., 1991).
6.3 SDG induces an apoptotic-like cell death
In comparing further the effects of SDG and H2 O2 , the mode of cell death 
induced by these agents has been assessed. A cell may die by one of two 
pathways, necrosis or apoptosis. Necrosis generally occurs in response to cell 
injury and results in cell swelling, loss of membrane integrity and ultimate lysis of 
the cell and release of its contents into the extracellular environment which elicits 
an inflammatory response. In contrast, apoptosis is a genetically programmed, 
delineated set of events that can be activated by numerous stimuli: it generally 
involves cell shrinkage, maintenance of membrane integrity and does not induce an 
inflammatory response since cell contents bud off in membrane bound vesicles, 
termed apoptotic bodies, which are phagocytosed (Wyllie, 1993). The 
morphological and biochemical characteristics of apoptosis have been extensively 
studied in glucocorticoid-induced apoptosis in thymocytes (Compton and 
Cidlowski, 1992). When treated with dexamethasone, rat thymocytes undergo 
apoptosis with the most notable characteristics being condensation of chromatin 
forming a crescentic mass at the edge of the nuclear membrane (Wyllie et al., 
1980) and formation of intemucleosomal 180-200bp DNA fragments (Wyllie, 
1980). While these morphological and biochemical characteristics have acted as 
standard criteria for defining apoptosis it is debatable as to how applicable these 
criteria are for assessing apoptosis in all cell systems induced with a variety of 
different treatments. For example, hepatocytes (Oberhammer et al., 1993) and 
oligodendrocytes (Barres et al., 1992) can undergo morphological apoptotic death 
in the absence of intemucleosomal DNA ladder formation. Therefore, in defining 
apoptosis many workers have adopted additional biochemical assays with which to
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assess apoptosis. For example, the formation of high molecular weight DNA 
fragments ranging from 50-600Kb can be detected during apoptosis (Walker et al., 
1991; Roy et al., 1992; Bicknell et al., 1994) and it has been suggested that this 
represents an earlier and more consistent step in apoptosis (Oberhammer et al., 
1993). Additionally, since apoptosis is an active process, anti-metabolites such as 
cycloheximide and actinomycin D, which inhibit protein and RNA synthesis, 
respectively, can prevent apoptosis (Zaleski et al., 1994). This, however, is not a 
consistent finding; other reports have found both agents to have either no effect 
(Kruman et al., 1992) or even induce apoptosis (Martin, 1993). The involvement 
of signal transduction pathways may also play a role in apoptosis since inhibitors of 
tyrosine kinases can prevent apoptosis (Migita et al., 1994; Yousefi et al., 1994). 
Additionally, the endonuclease activity thought to be responsible for apoptotic 
DNA fragmentation is dependent on Ca^+ and Mg^+ and this can be inhibited by 
metal chelators such as EDTA or Zn^+ (Compton, 1992). While these assays 
implicate an active cell death rather than necrosis, there is presently no single 
definitive biochemical test for the occurrence of apoptosis. For this reason, many 
workers rely mostly on morphological criteria to assess apoptosis, notably 
chromatin condensation, since this is the most striking feature of an apoptotic cell 
that can be detected by light microscopy. However, Kung et al. (1991), in 
studying the cytotoxic effects of aphidicolin and vincristine, showed that cell death 
could be prevented by cycloheximide, suggestive of apoptosis, but observed that as 
cells died they took up a number of different morphologies, not all relating to the 
apoptotic model of the thymocyte. Indeed, nearly 50% of the cells had no gross 
nuclear abnormalities. The role of nuclear changes in apoptosis is also brought 
into doubt by the ability of apoptosis to occur in cells lacking a nucleus (Jacobson 
et al., 1994). This suggests that while nuclear changes may be a diagnostic marker 
for apoptosis they may not be universal or functionally significant Therefore, true 
apoptosis, as defined in the thymocyte model, may only occur under some 
conditions whereas other apoptotic-like deaths may occur elsewhere; the form and
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extent to which cell death resembles classical apoptosis being dependent on the cell 
type and inducing agent
We and others have shown that both organic and inorganic 
seleno-compounds can induce apoptosis in diverse systems such as leukaemia and 
mammary cultured cells as judged by morphological criteria, formation of 
nucleosomal ladders and flow cytometry, which utilises the principle of differential 
uptake of two DNA-binding fluorochromes by apoptotic but not necrotic cells 
(Lanfear et al., 1994; Lu et al., 1994; Thompson et al., 1994). Similarly, hydrogen 
peroxide can induce apoptosis in a variety of cell systems as judged by , 
morphological criteria and the formation of nucleosomal DNA ladders (Pierce et 
al., 1991; Sandstrom et al., 1993; Nosseri et al., 1994; Forrest et al., 1994). In 
this study, SDG and H2 O2  were found to induce the formation of 560Kb DNA 
fragments and SDG caused further cleavage to 50Kb DNA fragments. It has been 
suggested that chromatin condensation during apoptosis reflects the cleavage of 
DNA into high molecular weight fragments (Oberhammer et al., 1993). However, 
in the present study cleavage of DNA occurred in the absence of any gross nuclear 
structure or chromatin changes. Fragmentation in the absence of chromatin 
condensation has also been observed by other workers when cells are treated with 
exogenous proteases or nucleases (Duke et al., 1994; Williams et al., 1994). 
While no nuclear morphological changes were observed, SDG and H2 O2  did 
however cause the appearance of cytoplasmic convolutions which is suggestive of 
apoptosis (Wyllie, 1992). These morphological and biochemical data therefore 
suggests that an apoptotic-like death may be induced in C57 cells by SDG and 
H2 O2  but that the pathways differ with respect to DNA fragmentation. However, 
in the absence of classical diagnostic morphological markers of apoptosis 
additional biochemical tests are required to further define the mode of cell death in 
this cell system.
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6.4 Mechanisms of selenium-resistance
A number of comparative studies of C57 and B19 cells were carried out in 
order to determine the possible mode of resistance displayed by the B 19 cells. As 
mentioned earlier, the mutations affecting selenium-resistance appeared to be 
acting downstream of early events in selenium-cytotoxicity such as selenite entry 
into the cell and reduction to SDG. One possibility therefore was that 
selenoproteins may be involved in selenium-resistance. The fact that the 
selenoprotein complement of C57 and B19 cells were very similar suggests that 
there are no gross changes in B19 cells affecting selenoprotein or selenium-binding 
protein synthesis and that the machinery for selenoprotein synthesis is probably 
intact. There were however a number of proteins whose levels appeared to differ 
between the two cell lines suggesting that selenium-resistance displayed by the B 19 
cells may involve selenium-labelling proteins. Their respective molecular weights 
do not correspond to those of any known selenoproteins suggesting these are as 
yet uncharacterised selenium-labelling proteins. It is also unknown if these 
proteins are true selenoproteins that contain [Se]Cys encoded by a UGA codon or 
selenium-binding proteins. Regarding the latter class of proteins, the differential 
labelling of these spots between the two cell lines may reflect selenium-binding 
activity rather than actual protein levels. Additionally, proteins 13 and 14 which 
appear to be only present in the B19 cells could represent post-translationally 
modified forms of protein 17 which has the same molecular weight but a different 
pi value. Such modifications could include phosphorylation which would be 
expected to alter charge of the protein without any significant change in molecular 
weight. In such a situation, absence of spots 13 and 14 from C57 cells may not 
necessarily represent an absence of protein but rather a different phosphorylation 
status.
A number of differences were also observed in gene expression levels 
between the two cell lines. The fact that both increases and decreases in mRNA 
levels were detected and that the levels of some mRNAs such as GPX, TRX, GST
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Yc, GSt 7t, bcl-2 and bcl-xL were unaltered suggests that the differences observed 
are specific and not just a result of some change affecting, say, the general 
transcription of RNA polymerase II dependent genes.
The mRNA levels of GST Ya and GST Yc, the sub-units that constitute 
GSt a, were approximately 2-fold higher in B19 cells. GST a overexpression is 
associated with resistance against nitrogen mustards (Lewis et al., 1988; Puchalski 
and Fahl, 1990; Giaccia et al., 1991). A 2-fold overexpression of GST a  could 
thus be functionally significant in conferring selenium-resistance. This would not 
necessarily require selenite, SDG or potentially other toxic seleno-metabolites to be 
substrates for GST a  since GST a  could be involved in downstream events of 
selenium-cytotoxicity such as detoxification of organic peroxides which might be 
generated. In this context, it should be noted that GST n mRNA levels were found 
to be considerably higher than GST a mRNA and therefore any role GST a may 
play in selenium-resistance might be expected to involve substrates specific to GST 
a rather than other GSTs, such as GST n.
Since SDG induced an apoptotic-like death it was of interest to examine 
the levels of various genes that are known to affect sensitivity to induction of 
apoptosis. bcl-2 mRNA levels were unaltered between the two cell lines. 
However, bcl-xg mRNA, the product of which antagonises the protective function 
of BCL-2, is down-regulated in B19 cells. Thus, if BCL-2 were to be involved in 
determining susceptibility to SDG-induced cell death, down regulation of bcl-x§ 
mRNA could confer selenium-resistance. The differential maintenance of bcl- 
xj^and bcl-xg mRNAs suggests that the down-regulation of bcl-xg mRNA is due 
to a post-transcriptional mechanism since bcl-XLand bcl-xg mRNAs are splice 
products from the same transcript (Boise et al., 1993).
Down-regulation of PHGPX mRNA in B19 cells was surprising since 
lowering the levels of PHGPX might be expected to sensitise a cell to both H2 O2 - 
and SDG-induced cytotoxicity. However, neither of these phenotypes were 
observed. Although PHGPX could not be definitively identified on the 2D protein
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gels, the most likely candidates are spots 24 and 25 since these were the major 
selenoproteins running at approximately 20KDa, which corresponds to the 
molecular weight of PHGPX. Interestingly, the intensity of these two spots was 
not significantly different between the two cell lines suggesting that the differences 
in mRNA levels may not be biologically significant
6.5 Physiological relevance of in vitro effects to in vivo anti-carcinogenic 
activity of selenium
Of a number of seleno-compounds, namely SBME, SMSC, DMS, selenite 
and [Se]Met, which have varying degrees of chemopreventive activity, only 
selenite had a significant effect on the growth of C57 cells. The relative 
ineffectiveness of SBME in comparison to selenite has also been shown on L1210 
leukaemia cells (Wilson et al., 1991). The lack of correlation between the relative 
efficiencies of seleno-compounds to inhibit growth in vitro and their relative 
effectiveness to inhibit tumorigenesis in vivo might argue against the hypothesis 
that the in vitro effects of selenium are mechanistically relevant to the 
anti-carcinogenic effects. However, it is becoming increasingly apparent that 
metabolism is an essential step in the anti-carcinogenic action of selenium. 
Although these critical metabolic pathways and metabolites have yet to be 
identified it is unlikely that all cells possess the metabolic machinery to generate 
active seleno-compounds. For example, the methyl-transferase thought to be 
involved in the final methylation step of selenium detoxification is mainly expressed 
in lung and liver (Mozier et al., 1988). Therefore one explanation for the lack of 
correlation between in vitro and in vivo studies could be that C57 cells cannot 
process all selenium forms to toxic metabolites whereas in vivo such metabolites 
may be generated by distant organs and then secreted and delivered to the site of 
action. Kato et al. (1992) showed that both inorganic (selenite) and organic 
([Se]Cys) forms of selenium after absorption are converted to a molecule 
designated A-Se which is highly extracted by liver but not other organs such as
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lungs or kidney. Additionally, absorbed selenium was excreted to a higher rate if 
the liver was bypassed using a portacaval shunt. The liver therefore plays a central 
role in selenium metabolism and homeostasis in the organism and may be important 
in metabolising selenium compounds to active chemopreventive agents.
It has been suggested that the in vivo anti-carcinogenic and toxic effects of 
selenium are directly related (Spallholz, 1994). However, these two properties of 
selenium have been shown to be dissociable. Ip et al. (1994a) introduced a 
chemopreventive index which gives an indication of the safety margin between the 
anti-carcinogenic and toxic doses of selenium. The chemopreventive index of a 
particular selenium compound is calculated as a ratio of the maximum tolerable 
dose, defined as the dose which produces the first indication of a significant 
decrease in growth of the animal, to the dose which produces a 50% reduction in 
tumour yield in the DMBA-induced mammary tumour model. If the 
anti-carcinogenic and in vivo toxic effects of selenium were mechanistically related, 
it would be expected that the chemopreventive index of selenium compounds 
would be constant. However, this is clearly not the case with chemopreventive 
indices of 1, 1.3, 4 and >10 being reported for [Se]met, selenite,
l,4-phenylene-bis(methylene)selenocyanate (p-XSC) and triphenylselenonium 
chloride, respectively (Ip et al., 1994a, 1994b). This raises the question of whether 
the in vitro cytotoxic effects of selenium are mechanistically relevant to the in vivo 
anti-carcinogenic action or toxic effects of selenium. While it is well established 
that selenite is cytotoxic in vitro, a number of studies have also claimed selenite to 
be a reversible inhibitor of growth and that this cytostatic action of selenite may be 
more relevant to the chemopreventive activity of selenium. Medina and Obom 
(1984) showed that selenite inhibited cell growth, as measured by cell number and 
DNA synthesis, but that growth resumed after selenite removal. However, since 
the clonogenic potential of cells after selenite removal was not assessed and 
recovery began only after a lag period of 2-4 cell doublings, it is therefore possible 
that resumption of cell growth was actually a measure of a sub-population of cells
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surviving selenite treatment rather than a true reversible effect. Similarly, 
Gruenwedel and Cruickshank (1979) demonstrated recovery of DNA, RNA and 
protein synthesis after selenite removal but this too only occurred after a lag period 
exceeding 3-4 generation times. While they also did not assess the clonogenic 
potential of cells after selenite removal, cell viability, as measured by trypan blue 
exclusion, indicated that more than 90% of the cells had intact membranes after 
selenite treatment. However, since selenium can induce apoptosis in some 
systems, membrane integrity may be an unsuitable assessment of cell viability since 
cell membranes of apoptotic cells remain intact until the later stages of apoptosis 
(Wyllie, 1985). Indeed, Lu et a l (1994) showed that during selenite-induced 
apoptosis of L I210 leukaemic cells, trypan blue exclusion was a poor indicator of 
long-term proliferative potential as measured by clonogenic assays.
The in vitro growth inhibitory effects of selenium appear to be dependent 
on its chemical form. While selenite cytotoxicity is associated with the induction of 
DNA strand breaks, SB and SBME at doses 5-fold higher than those used in the 
present study or lOOpM triphenylselenonium chloride can inhibit growth in the 
absence of DNA strand breaks (Wilson et a l , 1992; Ip et a l , 1994b). All three 
compounds are also superior to selenite with respect to chemopreventive efficacy 
(Ip and Ganther, 1990; Ip et a l, 1994a). The ability to inhibit growth in the 
absence of DNA strand breaks might suggest a specific mechanism which may be 
relevant to the anti-carcinogenic activity of selenium. On the other hand, the effects 
of selenite and SDG, such as the induction of apoptosis, may reflect a general 
response to cellular damage, such as DNA strand breaks, and therefore may be 
more relevant to the in vivo toxic effects of selenium. However, p-XSC which has 
a chemopreventive index that is 4-fold higher than selenite induces apoptosis more 
effectively than selenite in vitro suggesting that for these two compounds, at least, 
chemopreventive efficacy correlates with their ability to induce apoptosis in vitro 
(Thompson et a l , 1994). Additionally, the in vivo toxic effects of selenium, which 
is usually assessed as a decrease in body weight, may be due to a systemic
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mechanism rather than a direct effect on cells since growth retardation induced by 
feeding rats with high levels of selenite in the drinking water correlated with 
suppresion of growth hormone levels!(Thorlacius-Ussing et al., 1989). Moreover 
selenium-induced inhibition of growth rates could be reversed by administration of 
exogenous growth hormone (Thorlacius-Ussing et al., 1989). It is therefore presently 
unclear exactly how the in vitro and in vivo effects of selenium are mechanistically 
related since there is no clear correlation between the chemopreventive efficacy of 
a particular compound and the mechanism by which cell growth is inhibited in 
vitro. It is however possible that different selenium compounds may exert different 
anti-carcinogenic effects depending on their metabolic fates with some compounds 
inducing cell-death and others possibly having a cytostatic effect (Lu et al. , 1995).
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